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249: Higher order gene–gene interactions: Association
of CCL2, CCR5, IL8, AGT, ACE and AGTR1 gene
variants with type 2 diabetic nephropathy in Asian
Indians
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Diabetic nephropathy (DNP) is an important complication of type 2
diabetes, with 15–60% of patients developing persistent microalbu-
minuria, progressing to nephropathy and renal failure. Genetic
predisposition is a major determinant in the development of renal
complications of diabetes. The renin angiotensin system (RAS) and
the interlinked inflammatory cascade modulate the progression of
renal disease. We hypothesize that gene polymorphisms in the RAS-
cytokine pathway, through altered gene expression of inflammatory
cytokines, are potential factors that influence the susceptibility to
DNP. In the present study, we examined association of 13 single
nucleotide polymorphisms (SNPs) within seven candidate loci of
RAS cytokine pathway with DNP in Asian Indian subjects.
Research Design and Methods: We analyzed 13 SNPs (rs4311, I/D,
rs4343 in ACE, rs5050, rs4762, rs699 in AGT, rs5186 in AGTR1,
rs1024611, rs3917887 in CCL2, rs1982073, Tyr81His in TGFB1,
rs4073 in IL8, and Del 32 variant in the CCR5 genes) in 495 North
Indian subjects with type 2 diabetes [with and without nephropathy
(DM)] by using PCR–RFLP assay. We then reconstructed haplotypes
by combination of two genes (ACE and CCL2) present on the com-
mon locus chromosome 17q. We also assessed the gene–gene
interaction among the studied loci using multi-factor dimensionality
reduction (MDR) technique.
Results: Among the 13 loci examined, 6 were significantly associated
with increased risk of DNP in our population (ACE I/D, p = 0.004;
AGT, p = 0.0001; MCP I/D, p = 0.006; IL8, p = 0.02; CCR5,
p = 0.0001). Haplotype analysis (ACE and CCL2) revealed that
frequency of haplotype (G-I-T-D-G) was significantly higher
(p = 0.03) in DNP group as compared to DM group. Haplotypes
(A-D-C-I-A, A-D-C-I-G and G-D-C-I-G) conferred significantly
(p \ 0.04) lower risk and were protective. Epistasis observed with
MDR showed synergy between two loci rs699 (AGT) and CCR5 del
32 variant further conferring a four fold risk of developing DNP in
diabetics.
Conclusion: The RAS cytokine pathway is predisposing with ACE,
AGT, CCL2, IL8 and CCR5 gene variants being associated with
DNP. Gene gene interaction reveals synergy between CCR5 Del 32
and rs699 variants towards DNP development. Also, a high risk
haplotype on chromosome 17q, is associated with DNP in Asian
Indians.
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Introduction: The genes of Renin-angiotensin system are prime can-
didates of essential hypertension; angiotensinogen (AGT) gene G-6A,
T174 M and M235T polymorphisms are well reported potential
genetic markers. The aim of this study was to investigate association
of these polymorphisms to hypertension in a High Altitude (HA)
isolated population and also the prevalence of these three polymor-
phisms in the 24 indigenous populations of India covered under the
IGVdb.
Methods: In a case-control design, 540 consecutive ethnically-mat-
ched, high altitude subjects comprising 185 hypertensives and 355
controls were recruited. Genotyping by PCR–RFLP, genotypes
combinations and haplotype analyses were performed. In a parallel
study same polymorphisms were analyzed on illumina platform, in
552 healthy controls representing 24 indigenous populations covering
all corners of India.
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Results: The G-6A (rs5049), T174 M (rs4762) and M235T (rs699)
polymorphisms does not differed between the cases and controls in
this cohort (p = 0.88586, OR = 0.981, 95% CI = 0.755–1.274;
p = 0.928, OR = 0.978, 95% CI = 0.598–1.763; and p = 0.898,
OR = 1.017, 95% CI = 0.78–1.32, respectively). Three major hap-
lotypes were present with frequency[5%, viz GTM, ATT and AMT.
No significant difference was observed in these haplotype (p = 0.99,
OR = 1, 95% CI = 0.5584–1.7909; p = 0.89, OR = 1.04, 95%
CI = 0.596–1.81; and p = 0.93, OR = 0.95, 95% CI = 0.31–2.89).
The common risk haplotype distributions among the 24 Indian pop-
ulations were overlapping with the cardiovascular mortality data
obtained from registrar general of India.
Conclusion: The individual as well as interaction among G-6A,
T174M and M235T polymorphisms in combinations or haplotypes
does not associate with hypertension in this HA population. The
overlapping results of risk haplotype and mortality due to cardio-
vascular disorders in few ethnic groups do indicate of some genotype-
phenotype correlation.
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In Mexico, hypertension has a prevalence of 30.8% in population
[20-years-old. It is a risk factor for myocardial infarction, heart
failure, vascular disease, and renal failure. Different genetic variants
have been reported to be associated with hypertension, including
those in the Angiotensinogen (AGT), adrenergic beta-1 receptor
(ADRB1) and, angiotensin-II receptor type 1 (AGTR1) genes. To
analyze association of these variants with hypertension in the Mexi-
can population, we conducted a case-control study in 230 cases and
80 controls[65-years-old from Mexico City. We genotyped six SNPs
in AGT: C-532T (rs5046), G-218A (rs5049), A-20C (rs5050), G-6A
(rs5051), C3889T (rs4762) and C4072T (rs699); two SNPs in
ADRB1: A145G (rs1801252), C1165G (rs1801253); and one variant
in AGTR1: A1166C (rs5186), using TaqMan technology (AB, USA).
We determined allele frequencies, Hardy–Weinberg (HWE) equilib-
rium, and the odds ratios (ORs) in the dominant, recessive and
additive models for each genetic variant. All variants were in HWE
with a genotyping call rate higher than 95%. No association with
hypertension was shown for polymorphisms in the ADRB1 and
AGTR1 genes. In contrast, two genetic variants in the AGT gene
showed a significant association with hypertension in our Mexican
population: G-6A (OR 4.64; IC 95% = 1.8–11.5; p = 0.00008 in a
recessive model), and C4072T (OR 4.42; IC 95% = 1.74–11.2;
p = 0.0009 in a recessive model). The G-6A AGT variant was further
genotyped in 4 different Mexican Amerindian populations. Minor
allele frequencies in Mayas (0.17), Tepehuanos (0.06), Mixtecos
(0.08), and Zapotecos (0.10), were compared with those from the
HapMap populations: CEU (0.61), JPT (0.11), and YRI (0.06), indi-
cating significant differences mainly between Caucasian and
Amerindian populations. We are currently increasing the number of
cases and controls in our study, and will include a genome wide
association study to further characterize the genetic bases of cardio-
vascular disease in the Mexican population.
252: Chronic arsenic exposure impairs macrophage
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Arsenic is a well-known environmental contaminant, affecting millions
of people around the world. More than six million people in nine dis-
tricts in West Bengal are exposed to arsenic. Skin lesions including
premalignant hyperkeratosis, hallmarks of chronic arsenicism, have
been reported from the arsenic exposed population in West Bengal.
Arsenic is also known to be immunotoxic and immunosuppressive in
nature. Owing to the established roles of human macrophages in
immune defense, we investigated, whether chronic arsenic exposure
could affect adversely the structure and/or function of these major
immune cells. The cell adhesion capacity, nitric oxide production and
phagocytic capacity were studied in the macrophages of sixty five
arsenic exposed and sixty unexposed individuals. Primarily, there was a
significant loss of cell adhesion capacity in the macrophages of the
exposed individuals when compared to that of the unexposed group. In
addition, nitric oxide production as well as phagocytic capacity of the
macrophages were significantly (p less than 0.001) reduced in the
exposed group. Arsenic exposure also affected the RhoA-ROCK
pathway. Rho A-GTP levels have increased while Rho-GDI levels have
decreased in the exposed individuals, which in turn influence cell
adhesion and phagocytic property of the macrophages. Moreover,
chronic arsenic exposure modulated the secretion of various inflam-
matory cytokines to different extent: IL1B, IL6, IL8 and TNFa were
down regulated whereas IL10 secretion was upregulated in the exposed
individuals compared to the unexposed. Thus arsenic impairs the
immune systems of the exposed individuals. Again it is known that
genetic variations play an important role for arsenic susceptibility.
Since arsenic exposure could modify the inflammatory cytokine profile,
the polymorphisms in the genes coding for these cytokines might well
be implicated in arsenic susceptibility. Therefore, we have also
undertaken the association study of the polymorphisms of the candidate
genes like IL1B and IL10 with arsenic susceptibility. These studies
together, would explain the modulations caused by arsenic that leads to
arsenic susceptibility at the immunological level.
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Solid tumors can be broadly classified into two categories. Clinically
homogeneous aggressive cancers such as those of the pancreas, bili-
ary tract, liver, etc., exhibit low survival rates and patients succumb to
recurrent metastatic tumors following surgery, necessitating devel-
opment of efficient treatment strategies. On the other hand, clinically
heterogeneous cancers including those of the breast, colon, prostate,
etc., exhibit variable survival rates and tumor classification is essen-
tial for better patient management. It is widely believed that cancer
occurs due to genetic instability leading to multiple molecular per-
turbations in the genome, resulting in activation of oncogenes and
inactivation of tumor suppressor genes. In order to understand the
molecular basis for the highly aggressive pancreatic cancer, we
employed array-based Comparative Genomic Hybridization to iden-
tify recurrent copy number alterations (CNAs) that harbor important
oncogenes and tumor suppressor genes. We used genome-wide
expression profiling and real time RT-PCR to determine the subset of
genes located within the CNAs that exhibited comparably altered
expression levels. Our results revealed novel candidate oncogenes and
tumor suppressor genes involved in diverse pathways including cell
motility, apoptosis, mitochondrial oxidative phosphorylation and
chromatin remodeling. Studies are underway to characterize the role
of these genes in pancreatic cancer. In addition, we have commenced
a large scale multi-pronged molecular analysis of esophagous cancer
including characterization of known aberrations such as microsatellite
instability, Wnt signaling, and determination of p53 and EGFR status
and identification of novel aberrations using genomic approaches.
Results indicate important molecular differences between adenocar-
cinoma (common in western countries) and squamous cell carcinoma
(the second most common cancer in several population-based cancer
registries of the ICMR in India) of the esophagous (ESCC). Genomic
microarray studies have identified a novel recurrent amplicon at
10q21 in ESCC. Efforts are underway to identify the ‘driver’ onco-
gene(s) resident within this amplicon. Recently, we have initiated a
comprehensive characterization of sporadic and familial colorectal
cancer occurring in the young, an important problem in India. Results
have revealed molecular features in tumors occurring in young
patients that are distinct from those occurring in older patients.
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in Apolipoprotein A5 on lipid variables
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The incidence of Cardiovascular Disease in India is projected to be
the highest in the world, with an increasing number of young Indians
falling prey to the disease. Indians worldwide suffer from a triad of
high triglycerides, low HDL-C and high LDL-C. Elevated triglycer-
ides (TG) have been established as an independent risk factor for
Cardiovascular Diseases (CVD). The apolipoprotein A5 gene
(APOA5) has been shown to play an important role in determining
plasma triglyceride concentrations. Several Single Nucleotide Poly-
morphisms (SNP) in the APOA5 gene have been identified. These
include -1131T [ C, -3A [ G, S19W, and G185C and their rare
alleles are associated with elevated plasma TG levels in different
populations. No concise data has been published till date on these
polymorphisms in the Indian context. Therefore, in the present study
we have investigated a case-control study to determine the frequency
of these polymorphisms and also to evaluate whether they are asso-
ciated with an increased risk of Coronary Artery Disease (CAD).
Sixty patients with CAD confirmed by coronary angiography ([50%
stenosis in one or more arteries and stable or unstable angina) and
sixty controls (examined clinically and investigated by electrocardi-
ography to exclude CAD) have been analysed. The frequency of these
polymorphisms varies in our population for e.g., G185C, which is
associated with CAD in Chinese population, is not polymorphic in our
population (total of 120 individuals analysed). At least one of these
alleles -1131T [ C, -3A [ G, S19W was present in 30% of Indians
and the rare alleles are associated with significant elevation in plasma
triglyceride levels. The detailed results on the role of the above four
polymorphisms will be dealt with during the presentation.
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pancreatitis but may interact with SPINK1 and CTSB
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Tropical calcific pancreatitis (TCP) is a type of chronic pancreatitis
unique to developing countries in tropical regions and one of its
important features is invariable progression to diabetes, a condition
called fibro-calculous pancreatic diabetes (FCPD), but the nature of
diabetes in TCP is controversial. We analysed the recently reported type
2 diabetes (T2D) associated polymorphisms in the TCF7L2 gene using
a case-control approach, under hypothesis that TCF7L2 variants should
show similar association if diabetes in FCPD is similar to T2D. We also
investigated the interaction between the TCF7L2 variants and N34S
SPINK1 and L26 V CTSB mutations, since they are strong predictors of
risk for TCP. Two polymorphisms rs7903146 and rs12255372 in the
TCF7L2 gene were analyzed by sequencing in 478 well-characterized
TCP patients and 661 healthy controls of Dravidian and Indo-European
ethnicities. Their association with TCP with diabetes (FCPD) and
without diabetes was tested in both populations independently using
Chi-square test. Finally, a meta-analysis was performed for assessing
the overall significance irrespective of ethnicity. We dichotomized the
whole cohort based on the presence or absence of N34S SPINK1 and
L26 V CTSB mutations and further subdivided them into TCP and
FCPD patients and compared the distribution of TCF7L2 variants
between them. The allelic and genotypic frequencies for both TCF7L2
polymorphisms, did not differ significantly between TCP patients and
controls belonging to either of the ethnic groups or taken together. No
statistically significant association of the SNPs was observed with TCP
or FCPD or between carriers and non-carriers of N34S SPINK1 and
L26V CTSB mutations. The minor allele frequency for rs7903146 was
different between TCP and FCPD patients carrying the N34S SPINK1
variant but did not reach statistical significance (OR = 1.59, 95%
CI = 0.93–2.70, p = 0.09), while, the TCF7L2 variant showed a sta-
tistically significant association between TCP and FCPD patients
carrying the 26 V allele (OR = 1.69, 95% CI = 1.11–2.56,
p = 0.013). Type 2 diabetes associated TCF7L2 variants are not
associated with diabetes in TCP. Since, TCF7L2 is a major suscepti-
bility gene for T2D, it may be hypothesized that the diabetes in TCP
patients may not be similar to T2D. Our data also suggests that
co-existence of TCF7L2 variants and the SPINK1 and CTSB mutations,
Genomic Med. (2008) 2:303–330 305
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that predict susceptibility to exocrine damage, may interact to deter-
mine the onset of diabetes in TCP patients.
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Essential hypertension is a common complex condition posing a
major risk to life due to associated fatal complications like stroke,
coronary artery disease, end stage renal disease etc. Of the several
pathways implicated in essential hypertension Renin Angiotensin
(RAS) pathway has been studied in greater detail. Angiotensin II
Type 1 receptor (AT1R, encoded by the AGTR1 gene) is an important
component of RAS system that harbors several polymorphisms of
which a silent polymorphism A1166C (cytosine substituted by ade-
nine) in 3’ untranslated region is more prevalent. In the present study
638 essential hypertensive and 407 normotensives were studied for
demographic parameters. The mean age of the patients was
55.25 ± 9.64 while SBP and DBP were 154.99 ± 21.93
95.11 ± 11.76 respectively. There was preponderance of males
(63.0%) among hypertensives with higher incidence of smokers
(26.6%) and alcoholics (31.2%) compared to controls (smokers-
13.7%; alcoholics-20.14%). The mean BMI (26.73 ± 4.33) showed a
significant increase in hypertensives as compared to controls. 63.08%
of the cases reported positive family history. Lipid profiles though
were slightly elevated in hypertensives did not differ significantly
from controls. Analysis of 645 DNA samples (363-hypertensives and
282-controls) for the distribution of A1166C polymorphisms showed
significant difference (v2 -6.267, 2 df, p B 0.05) between patients
and controls with higher frequency of heterozygotes in patients (AA-
82.4, AC-16.3, CC-1.4%) as compared to controls (AA-89.4, AC-9.9,
CC-0.7%). Stratification of the data showed similar findings among
the sexes, cases with positive family history, obesity, habit of
smoking and alcohol consumption. When AC and CC genotypes were
pooled to compute risk for allele C carriers for hypertension signifi-
cant variation was observed between male patients and controls (odds
ratios of 0.556, CI-0.349-0.885; v2 -6.23; p B 0.025) and hyper-
tensive and control smokers (odds ratios of 0.18, CI-0.039-0.839
(v2 -5.802; p B 0.025).
The present study reveals high risk for AC heterozygotes at
AGTR1 locus for essential hypertension. The substitution of adenine
to cytosine does not affect the structure of the encoded protein but it
may be suppressing cellular AT1R synthesis in the presence of excess
angiotensin II-end product of RAS pathway that acts as a vasocon-
strictor causing elevation of blood pressure and hypertension.
257: Genetic alterations of the TP53 gene and their
influence on the risk of cervical cancer development
among HPV16/18 positive Indian women
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Introduction: Human papillomavirus infection is the major etiologic
factor for cervical cancer (CaCx), the foremost common cancer
among women of India and other developing countries. Proteolytic
degradation of TP53 gene mediated by viral oncoprotein E6, is one
mechanism associated with the pathogenesis of CaCx. Variations
within the TP53 gene might therefore affect disease risk.
Objectives:
1. Profiling of variations within the TP53 genomic region encom-
passing the ORF
2. Estimate the association of such variations (alleles and/or
genotypes) with CaCx among HPV16/18 +ve individuals
3. To identify haplotypes relevant for disease risk
Material and methods:
1. Sequencing of TP53 gene [7517561–7519995 of Chr. 17, (-)
strand] of 85 CaCx samples (53 HPV16/18 +ve) and 47 normal
samples (23 HPV16/18 +ve)
2. Determination of association of various genotypes or alleles with
disease from v2 or Fisher’s exact test
3. Construction of haplotypes using HAPLOVIEW 4.1.
Results: The variations recorded were a 16 bp duplication (intron 3), a
novel SNP A11299C (intron 3), SNP C11446G (exon 4) and a MspI
RFLP at C13494G (intron 6). Analysis restricted to HPV16/18 +ve
individuals revealed that the prevalence of intron 3 16 bp duplication
failed to differ between cases and controls. A allele at A11299C was
significantly (p = 0.003) overrepresented among cases (16.7%) than
controls (0%). C allele encoding a Pro at codon 72 (C11446G) was
significantly higher (Fisher’s p = 0.038) among cases (57.7%) than
controls (34.8%). Absence of MspI RFLP or GG at C13494G was
significantly overrepresented (p = 0.001) among cases (52.3%) than
controls (0%). Haplotype analysis based on A11299C-C11446G-
C13494G, revealed significant overrepresentation (p = 0.037) of C-
C-G haplotype among cases (12.4%) than controls (1.2%), while a
significantly decreased prevalence (p = 0.000) of C-G-C haplotype
was recorded among the cases (16.7%) than controls (56.25%).
Conclusion: A11299C polymorphism does not appear to be relevant
for CaCx development among HPV positive individuals in contrast to
the combinations of variations within exon 4 and intron 6 of TP53.
Since HPV16/18 infection is the initiating event for CaCx, the study is
highly relevant and calls for the correlation of the findings with viral
factors such as viral load and haplotypes, predominantly of HPV16,
prevalent within the population, to draw useful insights that might
lead to development of strategies for efficiently combating HPV
infections for prevention of CaCx.
258: CYP1A1, CYP2E1 and GSTP1 polymorphisms
and lung cancer risk among Filipinos
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University of the Philippines Manila, Philippines
While the putative association between individual genetic polymor-
phisms and cancer risk remains uncertain, current data strongly
suggest that relating it with epidemiological factors such as age, sex,
306 Genomic Med. (2008) 2:303–330
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ethnicity, environmental risk factors and gene–gene interactions
makes for a more accurate assessment of the association between
genetic polymorphisms and cancer risk. Using molecular epidemiol-
ogy studies, data can be generated which can lead to the identification
of genetically susceptible subgroups in relation to environmental risk
factors. Variations in genes such as those of the xenobiotic metabo-
lizing enzymes has been shown to be associated with susceptibility to
lung cancer in numerous epidemiological studies. A case-control
study was conducted to evaluate polymorphisms in the genes for
Phase I and II drug metabolizing enzymes, particularly glutathione-S-
transferase (GSTP1) and the cytochrome P450 enzymes, CYP1A1
and CYP2E1 and lung cancer among Filipinos. Association between
occupational exposure, consumption of red meat, alcohol intake and
cigarette smoke exposure were also determined. There were a total of
184 lung cancer cases and 204 age and sex-matched controls geno-
typed using PCR–RFLP techniques which were subsequently verified
through direct sequencing. After univariate analysis using age-mat-
ched logistic regression, none of the polymorphic alleles in GSTP1,
CYP1A1 and CYP2E1 showed any increased risk nor protective
effect for lung cancer among Filipinos.
259: HLA B serological types relevant for HPV16
positive cervical cancer development among Indian
women: significant impact on some viral factors
Damayanti Das, Bornali Bhattacharjee, Sharmila Sengupta
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Introduction: HPV infection is the major etiologic factor for cervical
carcinogenesis (CaCx). Only few HPV infected women develop CaCx
after a long latent period justifying the role of host and viral factors in
HPV induced carcinogenic transformation. HLA class I alleles are
relevant host factors as they participate in immune-surveillance
against the virus.
Objectives: To identify HLA B serological types that (1) predispose
towards or protect against HPV16 related disease development and
(2) influence some relevant viral factors (intactness of the viral E2
gene, and HPV16 viral load).
Materials and methods: HLA B serological types were identified by
sequence-based typing of exons 2 and 3 of the HLA B gene among 64
HPV16(+) CaCx cases, 35 HPV16(+) and 24 HPV(-) controls, and
the HPV16 E2 gene-intactness and viral copy number per 100 ng
DNA by Taqman assay. The findings were analysed using test of
proportion/Chi-squared trend test and Mann–Whitney test.
Results: Of the 24 identified HLA B serotypes, B*40 was most pre-
valent among the controls either HPV(-) (50%) or HPV16(+)
(37.14%) while B*35 among the cases (32.81%). There was a sig-
nificant trend of decreasing prevalence of B*51 serotype
(ptrend = 0.000) with increasing severity of lesions from HPV(-)
controls (41.67%) to HPV16(+) controls (5.71%) to HPV16(+) CaCx
cases (4.69%). Similar observation (ptrend = 0.000) was recorded for
B*81 when compared between HPV(-) controls (8.34%) and
HPV16(+) samples (controls and cases; 0%). Overall median HPV16
copy number was significantly higher (p = 0.000) among cases
(4.1 9 107) than controls (7.68 9 103), or when restricted to samples
harboring intact E2. Median HPV16 copy number within cases har-
boring intact E2 (5.25 9 107) was significantly higher (p = 0.023)
than within cases with disrupted E2 (4.52 9 103). Median viral copy
numbers in samples harboring intact E2 were significantly higher
among cases than controls within the serotypes B*07 (p = 0.040),
B*35 (p = 0.006) and B*40 (p = 0.000).
Conclusion: The study reflects the interdependent roles of host and viral
factors in HPV oncogenesis. HLA B*51 and B*81 serotypes are pro-
tective against HPV16 related CaCx development, while none appears
to enhance risk of HPV16(+) CaCx. The serotypes B*35, B*40 and
B*07 can potentially predispose HPV16(+) individuals to CaCx
through high viral loads. Further correlation of such findings with
population specific HPV16 lineages and haplotypes is likely to provide
useful insights towards developing modalities for combating CaCx.
260: Functional role of Acidic Mammalian Chitinase
polymorphisms in atopic asthma
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Background: Recent microarray expression studies in the mice model
of allergic asthma suggest Acidic Mammalian Chitinase (AMCase/
CHIA) to be a potential candidate gene in asthma pathophysiology.
The identification of CHIA gene variants associated with atopic
asthma could be useful in identifying individuals at risk for devel-
oping asthma.
Objective: To investigate the genetic and functional significance of
CHIA polymorphisms with atopic asthma and serum IgE levels in the
Indian population.
Methods: Twenty-one SNPs were identified by sequencing DNA from
60 individuals. On the basis of linkage disequilibrium, six polymor-
phisms were selected and genotyped in unrelated atopic asthmatics
(N = 270) and controls (N = 292); and an independent paediatric
cohort (Patients = 150; Controls = 101). The functional significance
was demonstrated by reporter gene assays.
Results: The rs3806448G/A promoter polymorphism showed signif-
icant association with atopic asthma (padult = 0.00001 and
ppaediatric = 0.0002) and serum total IgE (p \ 0.05). Also,
rs1049132C/T polymorphism was associated with serum total IgE in
patients (p \ 0.05). We generated a two locus haplotype using these
promoter SNPs and observed that GT was the most frequent protec-
tive haplotype, while AT was found to be the risk haplotype. This was
functionally correlated with its transcript level by transient transfec-
tion of the reporter constructs containing these SNPs into the human
lung epithelial carcinoma cell line A549. We observed that the con-
struct containing the risk promoter haplotype AT resulted in a
threefold increase in transcription (p \ 0.0013) as compared to the
protective promoter haplotype GT, suggesting that these promoter
SNPs are functionally associated with CHIA gene expression.
Conclusion: This is the first study demonstrating a significant associa-
tion of CHIA polymorphisms with atopic asthma and total serum IgE.
The functional relevance of this study may initiate further research in
elucidating the exact role of CHIA in asthma pathogenesis.
261: Genotype and tissue specific effects on alternative
splicing of the transcription factor 7-like 2 (TCF7L2)
gene in tissues important to type 2 diabetes (T2DM)
pathogenesis
1,2Swapan K. Das, 1,2Ashis K. Mondal, 1,2Winston S. Chu,
1,2Neeraj K. Sharma, 1,2Steven C. Elbein
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Single nucleotide polymorphisms (SNPs) of the TCF7L2 gene are the
strongest genetic risk factors for T2DM, but the variants are intronic
and of unknown function. TCF7L2 has multiple alternative splice
forms, but no data are available on alternative splicing in tissues
playing key role in T2DM pathogenesis. We hypothesized that
TCF7L2 SNPs altered T2DM risk by changing expression of alter-
native splice forms in human tissues involved in T2DM
pathophysiology. We isolated total RNA from human subcutaneous
(sc) adipose and muscle biopsy samples, and we complemented these
studies with HepG2 cells and a commercial total pancreas RNA
sample to identify all TCF7L2 splice forms using 50 and 30 RACE
technique and PCR based cloning. We quantified total and transcript
isoform specific TCF7L2 levels in sc. adipose of 78 healthy non
diabetic human subjects who were genotyped for SNPs rs7903146
and rs12255372 and who represented a wide range of body mass
index (BMI) and insulin sensitivity (SI). We also quantified alterna-
tive splice forms in human liver and (HepG2) and adipose cell lines
(SGBS) under different in vitro conditions. In adipose we found two
alternate 3’ ends of TCF7L2 mRNA, one isoform being 262 bp
shorter then the other. The shorter isoform was not observed in
muscle. We confirmed expression in all tissues of a previously
reported 69 bp alternatively spliced exon within intron 3 (exon 3a),
and identified a novel 141 bp alternatively spliced exon within intron
4 (exon 4a) expressed only in muscle tissue and HepG2 cells. In
muscle, we also observed a novel 235 bp exon formed by alternative
splicing of parts of exons 3 and 4. A 73 bp alternatively spliced exon
from within intron 13 (13a) was present in all tissues and was present
the most abundant isoform in the pancreas. We observed a total of 16
different TCF7L2 alternatively spliced transcripts, Based on screening
[80 clones each in adipose, muscle, pancreas and HepG2 cells, we
identified 8, 14, 8 and 10 isoforms, respectively. Whereas total
TCF7L2 levels in sc. adipose were not correlated with BMI or SI,
transcripts retaining exon 13a in adipose were significantly correlated
with BMI (p = 0.01) and % fat (p = 0.002). Furthermore, exon 13a
containing transcripts were significantly associated with genotype at
SNP rs7903146 (p = 0.03). These studies suggest that TCF7L2
intronic SNPs may alter alternative splicing or transcript-specific
stability of TCF7L2 in human adipose.
262: Risk of oral leukoplakia and cancer in relation
to HPV infection, polymprphisms at XRCC1 and TP53
and mutation in TP53 gene
1,2Puspita Das Roy, 1Mousumi Majumder, 1Bidyut Roy
1Human Genetics Unit, Indian Statistical Institute, 203, B.T. Road.
Kolkata 700108, India, 2Department of Biochemistry, University of
Calcutta, 35, Ballygung Circular Road, Kolkata-700019, India
Introduction: Apart from tobacco use, oncoproteins in HPV 16/18
have been reported to play important roles in oral carcinogenesis.
These oncoproteins can interact physically with different proteins like
TP53 and XRCC1, to increase genomic instability and thus the risk of
cancer. Polymorphisms in these genes may also affect the interaction
between these proteins and HPV oncoproteins and, hence, modulate
the risk of diseases in HPV infected individuals.
Aim: In this study we analyzed (a) HPV infection, (b) polymorphisms
in XRCC1 and TP53 and (c) somatic mutations in TP53 to estimate
the contribution of these factors to oral carcinogenesis.
Methods: Tissue DNA from 274 samples (83 cancer, 91 leukoplakia,
100 controls) were screened for (a) HPV 16/18 infection, (b) poly-
morphisms in XRCC1 and TP53 by PCR-RFLP to estimate the risk of
disease independently and jointly and (c) somatic mutations (com-
pared with blood DNA) in exons 5–9 of TP53 by resequencing to
determine the relationship between HPV infection and TP53
mutation.
Results: (a) HPV infection was significantly associated with increased
risk of leukoplakia and cancer (OR = 2.8, 95% CI = 1.2–6.5 and
OR = 5.5, 95% CI = 1.6–19, respectively). (b) Genotypes at three
polymorphic sites in XRCC1 did not modulate the risk of diseases
independently. Pooled variant haplotypes were overrepresented in
overall leukoplakia and HPV non-infected leukoplakia samples
(OR = 1.8, 95% CI = 1.2–2.8; OR = 2.2, 95% CI = 1.2–4.0,
respectively) but not in cancer samples. The Arg/Arg genotype in
TP53 marginally increased the risk of leukoplakia in overall samples
(OR = 2.5, 95%CI = 1.0–6.6) but not in HPV stratified leukoplakia
samples. (c) Five mutations in TP53 gene were detected in five cancer
tissue samples and the changes are: C [ T (Arg [ Cys), C [ T
(Arg [ Trp) and C [ T (Arg [ stop) at exon 8, G [ A (Arg [ His)
at exon 5 and C [ T at intron 9.
Conclusion: The association between variant haplotypes in XRCC1
and risk of leukoplakia is pronounced in HPV non-infected individ-
uals probably because in infected samples viral oncoprotein could
directly inhibit the DNA repair activity of XRCC1 and thus the effect
of any polymorphisms in XRCC1 will not be evident. Although TP53
Arg/Arg increased the risk of leukoplakia but the finding needs to be
validated in a larger sample population. Mutations in TP53 were
observed in both HPV infected and HPV non-infected cancer tissues.
Except for the one nonsense mutation, significance of other mutations
in TP53 is yet to be determined.
263: A common genomic variant in 9p21 associated
with premature coronary artery disease in Asian
Indians
1D. Dash, 1A. Maitra, 1J. Shanker, 1P. R. Sannappa, 1A. P. Das,
1S. John, 1V. S. Rao, 1H. Sridhara, 1,2V. V. Kakkar
1Thrombosis Research Institute India, Narayana Hrudayalaya
Hospital, 258/A Bommasandra Industrial Area, Anekal Taluk,
Bangalore 560099, India, 2Thrombosis Research Institute, Emmanuel
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Coronary artery disease (CAD) is a complex disorder with a broad
pathological spectrum and involves both genetic and environmental
risk factors. Recent studies have reported the association of multiple
common variants, in the 9p21 genomic region, with premature CAD
and abdominal aortic and intracranial aneurism in the Caucasian
populations. Asian Indians have a high susceptibility to premature
CAD and its associated risk factors. The present study was conducted
to investigate the association of a 9p21 variant, rs10757278, with
premature CAD in Asian Indian population. All participants included
in the study were recruited in the Indian Atherosclerosis Research
Study (IARS). Genotyping of rs10757278 was performed by a novel
method based on real time PCR in 154 affected individuals with
strong family history of CAD and 160 healthy controls. The geno-
typing results were confirmed by sequencing. The G allele frequency
was found to be 0.56 in our cohort. The unadjusted odds and the
adjusted odds ratio following correction for age, diabetes and
hypertension were estimated as 2.19 (95% CI: 1.04–4.64) and 2.15
(95% CI: 1.02–4.6), respectively (observed p = 0.0098, empirical
p = 0.016), in men. The data supported a recessive model for the
protective A allele (unadjusted p = 0.034, adjusted p = 0.016). Our
findings are in agreement with the trend observed in other populations
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and implicate the 9p21 common variant, rs10757278, in premature
CAD in Asian Indians. These results might contribute substantially to
the development of the 9p21 chromosomal variants into important
markers for the early detection of individuals at genetic risk of CAD.
264: Gilbert’s syndrome: Genetic factors
and their interactions
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Introduction: Gilbert’s syndrome (GS)—hallmark: moderate to high
unconjugated bilirubin (UCB) levels—is associated with a dinucleo-
tide TA insertion in the UGT1A1 promoter. The insertion is neither
necessary nor sufficient to cause GS. Hence, the search for other
causal and interacting genetic factors is crucial.
Aims: To quantify the (a) extent of association between the TA
insertion and GS, (b) involvement of other candidate genes, and (c)
interaction between GS and haemoglobinopathies (HB*), since HB*
also increases UCB.
Methodology: (1) Unrelated individuals from eastern India were
recruited from 4 groups: (1) UCB level in normal range and (a)
without HB* (n = 143) and (b) with (n = 41); (2) UCB level higher
than normal and (c) without HB* (n = 79) and (d) with (n = 92). (2)
Resequencing was done for UGT1A1 promoter, PBREM (3 kb 50 of
UGT1A1; known to modulate UCB in response to phenobarbital) and
SLCO1B1 promoter. (3) Data were statistically analysed.
Results and Inferences: (1) Age-effect on UCB was not significant in
males (p = 0.73) and females (p = 0.265). (2) Significantly different
(p \ 0.0001) mean UCB levels (mg/dl) in the 4 groups were: (a) 0.36,
(b) 0.49, (c) 2.98 and (d) 3.33. (3) The % homozygous for the
insertion in UGT1A1 promoter were: (3.1) 83% in GS cases [Group
(c)], implying that the insertion was not responsible for GS in 17% of
cases; (3.2) only 51% in Group (d), possibly indicating that the
insertion in presence of HB* is deleterious [supporting fact: among
insertion homozygotes with higher than normal UCB level, those with
HB* had significantly (p = 0.03) higher mean UCB level (4.07) than
those without (2.98)]; (3.3) 22% in Group (a), and (3.4) 29% in Group
(b), indicating that 22–29% of TA insertion homozygotes have normal
UCB levels. (4) We detected 2 SNPs (rs57409706, rs10929302) in
PBREM; genotype frequencies at both loci different significantly
(p \ 0.0001) among the groups; each with a significant impact (not
independent of the effect of the insertion) on UCB. (5) A remarkable
structure comprising modal Yin-Yang haplotypes, TG- and GA+
[-, + = without and with insertion; (T, G) and (G, A) are alleles at
the two PBREM loci], was observed, with frequencies (%) in the 4
groups: (a) 42,40; (b) 28,52; (c) 5,84; (d) 24,59. Thus, among HB*
individuals, the % of the TG- haplotype is halved compared with
normal individuals, with a concomitant increase in GA+. (6) Varia-
tions in SLCO1B1 promoter did not significantly alter UCB.
265: Possible protective role of ARNT gene in low risk
for Type 2 Diabetes Mellitus in Raica community
of Rajasthan
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The identification of genetic components of Type 2 diabetes (T2DM)
has become a real challenge so as to facilitate the disease under-
standing, its complications, treatment, cure and most importantly
prevention. It has already been shown that beta cell dysfunction is a
central component of the pathogenesis of T2DM. Across the globe a
lot of genes have been studied to understand the pathways behind the
disease etiology and one such genes is ARNT. The ARNT gene is
crucial for normal development of the embryo and is known to control
expression of several other genes. Thus, being a transcription factor
this gene serves as a master regulator of many cell functions and is
being looked upon as a potential site to integrate genetic and envi-
ronmental insults responsible for pathogenesis leading to T2DM.
ARNT gene is known to be involved in development of abnormalities
in insulin secretion and indeed ARNT gene expression has been
reported to be decreased in islets from humans with T2DM. The
prevalence of T2DM is very low, only 0–0.4% in the Raica com-
munity from North–West of India. Thus in the present study the
frequency of various ARNT alleles has been studied in the Raica
community and other Non-Raica subjects from Rajasthan. The study
was conducted in 57 individuals from the Raika community and 75
individuals from Non-Raika communities. DNA samples were gen-
otyped using a PCR–RFLP method. The two groups were also
compared for various anthropometric and clinical parameters. Indeed
all risk factors studied were very much controlled in the Raica
community individuals in comparison to Non-Raika community
members. The allele typing results revealed a similar frequency of
ARNT alleles in both the Raika and non-Raika subjects. In conclu-
sion, it can be said that the ARNT G1511A polymorphism as such
does not seem to be responsible for the very low incidence of T2DM
in the Raica community from Rajasthan.
266: A case of balanced reciprocal translocation
t(3;14)(p12;q12 ~ 13) associated with Bad Obstetric
History
Usha Dutta, Rajitha Ponnala, Ashwin Dalal
Centre for DNA Fingerprinting and Diagnostics, ECIL Road,
Nacharam, India
Human chromosomal aberrations are one of the major causes of a dis-
ease phenotype. Identification of such aberrations plays a major role in
mapping of the disease genes. Here we report a 30year-old male referred
for chromosomal analysis due to the Bad Obstetric History (BOH) of the
spouse. Cytogenetic analysis had revealed a balanced reciprocal
translocation involving chromosome 3 and 14. The karyotype was
assigned as 46,XY,t(3;14)(p12;q12 * 13). Fluorescence in situ
hybridizations (FISH) using whole chromosome paints of chromosome
3 and 14 confirmed the translocation. Analysis of the gene content of the
break point regions showed that the 14q12 * 13 is mapped to a locus
for PAX9 gene, a novel member of the paired box-containing gene
family. The history showed that his wife had two neonatal deaths one, an
anencephalic child and the second child showed absence of stomach
bubble and oesophageal atresia. Here the PAX9 gene in association with
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the BOH is discussed in detail. As per our knowledge this is the first
report involving these balanced reciprocal translocation breakpoints in
association with BOH.
267: The Generic-DataSHaPER, a step towards
the global harmonization of biobanks
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Sample size calculations taking realistic account of bio-clinical
complexity indicate that to comprehensively study the etiological
determinants of a complex disease, one ideally needs a minimum of
5,000 cases, and if interest focuses on a gene–gene or gene-life-style
interaction, at least 20,000 cases is preferable. But, with rare excep-
tions, individual biobanks do not contain, and cannot collect, this
many cases. In order to optimize the return from investment in bio-
banking, it is therefore essential to harmonize. Harmonization can be
defined as a set of procedures that promote the effective interchange
of information and samples between studies, accepting that there may
be important differences between them. Biobank scientists have
enthusiastically embraced the concept of harmonization, but success
demands concrete, scientifically led, actions and effective tools.
A common set of information (including health outcomes, health
determinants and physical measures) that may be used by and
shared between biobanks has been developed by P3G (the Public
Population Project in Genomics) and partner organizations. The
Generic-DataSHaPER (Generic Data Schema and Harmonization
Platform for Epidemiological Research) supports the construction of
baseline questionnaires for general purpose biobanks enrolling
middle-aged participants. It covers 60 domains of interest (history of
diseases, physical activity, anthropometric measures, etc.) and 250
variables (smoking status, birth location, etc.) and is comprehensive
enough to ensure the realization of valid research. The Generic-
DataSHaPER is a collaborative project involving experts from more
than 25 international biobanks. Its development was guided by a
comprehensive review of questionnaires used by population-based
biobanks and by the scientific input of international experts. The
current version is available on the P3G Observatory website (http:
//www.p3gobservatory.org/datashaper/explorer.htmIt). Already, eight
large population-based biobanks (1 million participants) have used
or plan to use the Generic-DataSHaPER in their information col-
lection. Although other key issues—e.g., ethical constraints and
quality control assurance—are pivotal to achieving valid sharing of
information, the creation of the DataSHaPER is an essential step on
the road to effective harmonization. The structure and development
of the DataSHaPER will be described, as well as its successes to
date and potential uses in biobank harmonization.
268: Evaluation of the frequency of PCOS in patients
with breast cancer
1N. Ghasemi, 2M. R. Mortazavi, 2A. Khorasani
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Polycystic ovary syndrome (PCOS) is a heterogeneous, complex
genetic disorder characterized by hyperandrogenemia,
hyperinsulinemia, insulin resistance, and chronic anovulation. It is the
most common endocrine disorder in women of reproductive age with an
enigmatic pathophysiologic and molecular basis. Obesity, hyperan-
drogenism, and infertility occur frequently in PCOS, which mostly have
a genetic predisposition, and are features known to be associated with
the development of breast cancer risk. This is a case-control study,
which compared PCOS frequency in patients with premenopausal
breast cancer and the healthy control group with normal mammography
in last 6 months. The data analyzed with SPSS 13.0 software using chi-
square test. Eleven patients (6.62%) in case group and 16 patients
(9.63%) in control group had polycystic ovary syndrome according to
their questionnaire. The difference was not significant (P = 0.645). In
conclusion, there was no relationship between frequency of polycystic
ovary syndrome and breast cancer. This might be due to the age of
patients with breast cancer in this study, which was mostly over 40. It
could be significant if the patients were chosen in lower age for showing
more effect of genetic than environment.
269: Evaluation of single nucleotide polymorphisms
in Peroxisome Proliferator Activator Receptor-c
(PPARG) and Tumor Necrosis Factor-a (TNF) genes
in obese Asian Indians: A population based study
1Rajeev Gupta, 2Namita Bhagat, 3Anoop Misra, 2Mukta Agrawal,
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Background: Obesity is rapidly emerging as a major public health
problem in India. It has a strong genetic component and multiple
genetic polymorphisms have been implicated. To determine the
association of Pro12Ala polymorphism in PPARG gene and
Gly308Ala polymorphism in TNF gene with obesity in North India
we performed a population based case-control study.
Methods: In an obesity-prone community in Jaipur we performed a
population based study using stratified random sampling. Of the 1,400
eligible subjects 20 years or more age we could recruit 1,127 subjects
(80.5%). There were 201 (17.8%) subjects with body mass index
(BMI) [ 30 kg/m2 (Group 1) and 143 subjects with BMI \ 20 kg/
m2 (Group 2). Clinical, anthropomric, biochemical and nutritional
details of these subjects were obtained. SNPs were estimated using
PCR–RFLP technique after standardization. Inter-group significance
was determined using Chi-square test and logistic regression was used
to determine univariate and multivariate associations.
Results: There were more women in Group 1 (119, 59.2%) as com-
pared to Group 2 (62, 43.4%) (p = 0.004). In Group 1 the prevalence
(%) of truncal obesity (49.8 vs. 19.6%, p \ 0.001), hypertension (71.1
vs. 46.8%, p \ 0.001), high total cholesterol (29.9 vs. 18.2%,
p = 0.006), low HDL cholesterol (28.9 vs. 23.1%, p = 0.031), and
diabetes (29.9 vs. 12.6%, p = 0.001) was significantly greater. There
was no homozygosity in the studied SNPs. Heterozygous Pro12Ala
polymorphism in PPARG was in 18 subjects (5.2%); 15 (7.5%) in
Group 1 and 3 (2.1%) in Group 2 (p = 0.028) and heterozygous
Gly308Ala polymorphism in TNF in 26 subjects (7.6%), 19 (9.5%) in
Group 1 and 7 (4.9%) in Group 2 (p = 0.115). Presence of poly-
morphism of PPARG as well as TNF genes significantly predicted
obesity with univariate odds ratio (95% confidence intervals) of 2.25
(1.32–3.84, p = 0.003) and 1.48 (1.10–1.99, p = 0.009), respec-
tively. These odds ratios remained significant after multivariate
adjustments for gender and co-morbidities at 1.74 (1.03–2.93,
p = 0.038) for PPARG and 1.46 (1.05–2.03, p = 0.024) for TNF.
Addition of dietary and physical activity variables did not result in
significant change in odds ratios.
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Conclusions: Asian Indian obese subjects have significant presence of
Pro12Ala polymorphism in PPARG and Gly308Ala SNP in TNF
genes. The significance remains after adjustment for co-morbidities
and dietary and lifestyle variables suggesting direct pathophysiolog-
ical influence of these genes.
270: Expression-based gene interaction networks
for breast cancer
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Lance Miller, Anbupalam Thalamuthu
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Breast cancer has become one of the most intensely studied human
malignancies in the genomic era. Given the grossly heterogeneous
nature of the disease, the notion that a profile comprising of multiple
genes, rather than any single gene or other parameter, will be more
predictive of tumor behavior is both appealing and reasonable.
Therefore, is growing indications that gene–gene interactions may
underlie the susceptibility to common human diseases such as breast
cancer. It is hypothesized that epistasis is a ubiquitous component of
the genetic architecture of common human diseases and that complex
interactions are more important than the independent main effects of
any one susceptibility gene. In this study we analyzed five indepen-
dent microarray datasets in order to investigate epistatic interactions
that may be the underlying breast cancer subtypes. We present a
method to construct gene expression networks using the measure of
interaction entropy between gene pairs. Information gain or interac-
tion gain (IG) is described as a measure of the strength of an
interaction between attributes and the class label such as case-control
status (Jakulin and Bratko 2003 and Jakulin et al. 2003). The decision
about the strength of an interaction is based on this p-value of the
interaction, visualized as an interaction graph. The results provided
five interaction graphs from the five datasets. Functional inter-relat-
edness of the genes in various molecular events in these five
interaction graphs were analyzed by data mining various knowledge-
based function annotation and pathway databases like GO, KEGG,
HPRD and Reactome. Additionally, we have also attempted to
incorporate logic rules (AND, OR, NOT) between the interacting
genes using Boolean Logic minimization methods for enhancing our
interpretation of the relationship between the genes. Though, the
results of our analysis have shown largely non-overlapping interacting
genes networks, individually they appear suggest biologically plau-
sible and convincing models for the disease etiology.
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Sarcoidosis is a complex chronic inflammatory disorder with predom-
inant manifestation in the lung. In the first genome-wide association
study ([440,000 SNPs) of this disease, comprising 499 German sar-
coidosis patients and 490 controls, we detected a series of genetic
associations, the most prominent being with the ‘‘SARC2’’* gene on
chromosome ten. Validation in an independent sample (1,649 cases,
1,832 controls) confirmed the association (SNP rs00*: P = 3.0 9 1013,
rs01*: P = 1.0 9 10-5, allele-based test). Extensive fine mapping
located the association signal to a region between exons 5 and 14 of
SARC2. A common non-synonymous SNP (rs02*, T [ C, p.Arg00*-
Cys) was found to be strongly associated with sarcoidosis. The GWAS
lead SNP and additional risk variants in the region (rs03*, rs04*, rs05*)
were in strong linkage disequilibrium with rs02*. The SARC2 protein
has complex and essential functions in several biological pathways,
including apoptosis and proliferation. We also examined the association
of SARC2 with other granulomatous diseases (e.g., Crohn disease,
rheumatoid arthritis). Data suggest a potential relevance of SARC2 as a
risk gene for phenotypic related disorders and indicate it as a suscep-
tibility locus of general importance.
272: Association of ACE I/D, ADD1 G460W
polymorphisms in ischemic and hemorrhagic stroke
in North Indian patients
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Introduction: Stroke is a leading cause of mortality and morbidity in
India. Genetic predisposition for stroke has been reported world-wide
but there is a paucity of genetic study on stroke in North Indian
population. Stroke is heterogeneous, multigenic with conventional
risk factors playing complex role in pathogenesis. ACE and Adducin
variants play a role in essential hypertension which is a known risk
factor for stroke. Therefore, this study was aimed to assess the role of
genetic variants of angiotensin converting enzyme (ACE) I/D
(rs4646994), Adducin (ADD1) G460W (rs4961), in Ischemic and
Hemorrhagic stroke in North Indian patients.
Methods: A case control study was performed in 414 subjects (136
Ischemic stoke, 128 hemorrhagic stroke, 150 controls) to evaluate the
frequency of polymorphisms of Angiotensin Converting Enzyme
(ACE) I/D (rs4646994), Adducin (ADD1) G460 W (rs4961), in
Ischemic and Hemorrhagic stroke in North Indian patients. Subjects
were genotyped through PCR/PCR–RFLP. Data was analysed by Chi-
square test and logistic regression model.
Results: DD genotype of ACE gene was associated with Hemorrhagic
stroke [OR = 2.924 CI (1.30–6.54), P = 0.009]. WW genotype of
ADD1 gene conferred risk in Hemorrhagic patients [OR = 2.03 CI
(1.14–3.16), P = 0.01] but W allele did not modulate the risk in
Ischemic stroke [OR = 0.591 CI (0.358–0.975), P = 0.03]. Both W
allele and D allele of ADD1 and ACE imparted risk in Hemorrhagic
stroke with OR = 2.035 CI (1.14–3.6), P = 0.00, OR = 2.21 CI
(1.44–3.40) P = 0.00, respectively.
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Conclusion: DD genotype of ACE and WW genotype of ADD1
modulated risk only in Hemorrhagic stroke patients who were more
associated with hypertension. However, further studies are required to
prove the protective effect of W allele in Ischemic stroke patients.
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Variants in FTO (fat mass and obesity associated) gene are associated
with obesity and type 2 diabetes (T2D) in white Europeans. These
associations are not consistent in Asians and there are few reports in
South Asian Indians who develop T2D at a much lower body mass
index (BMI) than that in the white Europeans. We studied the asso-
ciation of FTO variants with T2D and measures of obesity in South
Asian Indians in Pune, India. We genotyped by sequencing, two SNPs
rs9939609 and rs7191344, in the FTO gene in 1,453 type 2 diabetes
patients and 1,361 controls and a further 961 population based indi-
viduals from India. We observed a strong association of the minor
allele A at rs9939609 with T2D (OR per allele = 1.26 [95% CI, 1.13–
1.40], P = 3 9 10-5). The variant was also associated with BMI but
this association appeared to be weaker (0.06SDs; 95% CIs: 0.01–0.10,
P = 0.017) than the previously reported effect in Europeans (0.10SDs
95% CIs: 0.09–0.12). Unlike in the Europeans, the association with
T2D remained after adjusting for BMI (OR per allele for T2D = 1.21
(95% CI, 1.06–1.37); P = 4.0 9 10-3). Similar results were obtained
using waist circumference and other anthropometric parameters. Our
study replicates the strong association of FTO variants with T2D in
South Asian Indians but suggests that the association of FTO with
T2D in them might operate through mechanisms other than obesity.
This could imply underlying differences between Indians and Euro-
peans in the mechanisms linking body size with T2D.
274: Interleukin 13 gene is a risk genetic factor
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Introduction: Asthma is a complex multifactorial disease caused by
environmental influences and at least one hundred of predisposing
genes. However, only 14 of them have been replicated in more than ten
independent analyses. It is possible that those data have arised from
limited statistical power of some studies, but increasing evidences
suggest that the results are due to the background genetic differences
between ethic groups, which also could explain the differences in the
prevalence of the disease and the treatment responses of the patients
from several populations. One of the highest replicated association
results has been found with single nucleotide polymorphisms (SNPs) in
the Interleukin 4 (IL4) and 13 (IL13) genes, however, there are not
reports of association with asthma in Mexican patients.
Objective: The present study was undertaken to investigate the
association between the IL4 and IL13 SNPs and asthma in Mexican
pediatric patients.
Material and methods: Two hundred and forty unrelated asthmatic
patients and 408 healthy controls were recruited from three tertiary
medical center from Mexico, City. Patients and controls were geno-
typed to rs2243250 (C/T) and rs2070874 (C/T) on IL4 and rs1800925
(C/T) and rs1881457 (C/T) on IL13 using TaqMan assay. Hardy–
Weinberg equilibrium (HWE), haplotypes analyses and statistical
significances were performed with FINETTI, HAPLOVIEW and
STATCAL software. To evaluate stratification, ten validated admix-
ture markers were included.
Results: Gender ratio male:female in our cases were 1.8:1(64%: 46%).
Genotype distributions were in HWE in patients and controls. When
IL13 genotypes and allele frequencies were compared between cases
and controls a evidence of association was observed to both IL13
polymorphisms: rs1800925 (OR 1.32, IC 95% 1.02–1.7, P = 0.02) and
rs1881457 (OR 1.38, IC 95% 1.07–1.7, P = 0.01). Homozygote
genotype TT to rs1881457 SNP increased the risk to asthma (OR 2.02,
IC 95% 1.1–3.6, P = 0.02). Statistical significances in the TC IL13
haplotype frequency were found (OR = 1.4, IC 95% 1.01–1.8,
P = 0.005). CC IL13 haplotype were present only in female group.
Frequencies of IL4 polymorphisms between cases and controls were
similar and diferences were not significant. Frequency of TCTT hap-
lotype including IL4 and IL13 SNPs, was significant higher in cases as
compared to controls (OR = 1.29, CI 95% 1.01–1.66, P = 0.03).
Conclusions: Our data suggest that IL13 but not IL4 gene is a risk
genetic factor to asthma in Mexican pediatric patients.
275: Leptin (LEP) gene: The missing link between
the depression, obesity and metabolic disorders
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Background: Epidemiological data have suggested an association
between obesity and depression, but findings vary across different
studies. Depression and obesity are associated in several ways. First,
both are prevalent and disabling disorders influenced both by genetic
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and environmental factors. Second, depression, as obesity, seems to
be a risk factor for other metabolic disorders like hypertension and
cardiovascular disorders. Thirdly, both disorders are associated with
less control over appetite, as depressive people tend to eat more or
less than their regular energy needs. This fact makes leptin (LEP)
gene a probable candidate for common link between both disease
states. Aims: Present study is the first attempt which considers the
symptoms of depression, metabolic disorders and anthropometric
markers in relation to obesity to find possible associations between
these. Methods: Blood samples were collected from 150 depressed
individuals and an equal number of control subjects without any
history of psychiatric disorders visiting Psychiatric unit of BDK
Hospital Jhunjunnu and the medical centre facility in BITS, Pilani,
Rajasthan. Written informed consent was obtained from each indi-
vidual or from his/her guardian (in cases of severe depression). The
subjects were administrated a questionnaire to inquire about their
disease history, occupation, age and socioeconomic status. The
anthropometric markers like height, weight, hip and waist circum-
ference were recorded for each subject. DNA was extracted from the
PBL’s using standard lab procedures. Repeat polymorphisms were
detected using PCR–SSLP method. Gels were analyzed by two
independent observers for scoring the polymorphism. Data obtained
was analyzed with appropriate statistical tools using software like
Prism (Graph pad), MEDCCAL and SPSS. Results: A significant
difference (p \ 0.05) was observed in cases and controls for the
presence of metabolic disorders and \15 repeats of D7S1875 poly-
morphism. The values of BMI, WHR, SBP, DBP and FBG were
significantly elevated in individuals with \15 repeats of D7S1875
polymorphism when compared with the age matched controls
(p \ 0.01). Conclusions: These results provide first hand evidence
that leptin gene may be the possible link between the metabolic
disorders and obesity. Data to be presented, will discuss this
involvement of leptin gene not only in human obesity and the met-
abolic disorders but also their associations with the symptomatology
of depression.
276: APOE and CAPN gene and risk for the metabolic
complications in diabetes
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The diverse incidence of the T2DM across the world and the fact that
T2DM is associated with variety of metabolic complications indicates
that both the genetic and environmental factors interact to trigger the
onset and prevalence of this disease. A high waist to hip ratio (WHR),
Body Mass Index (BMI), hypertension and abnormal lipid profiles are
taken asrisk factors for T2DM. Infact a gene known to be associated
with dyslipidemiais Apolipoprotein E (APOE) gene, which syner-
gistically, in interaction with other genes controls the etiology of
T2DM. ApoE, known to play a major role in cholesterol metabolism,
is a 299 amino acids long protein and is responsible for transporting
lipoproteins, fat-soluble vitamins and cholesterol. This gene is poly-
morphic with three common isoforms (apoE4 (Cys112 [ Arg), apoE3
and apoE2 (Arg158 [ Cys)) known. Infact a heterogeneous distri-
bution in the APOE polymorphism is expected in the Indian
population, probably due to an admixture of Dravidians (mostly South
Indians), Aryans (North Indians), Afro Indians (living in Andaman
Nicobar island), Austro-Asiatic and Tibeto-Burmans etc. Another
interesting gene conferring a high risk for T2DM in Mexican-
Americans is CAPN 10. It has been also recognized as a risk factor for
increased serum cholesterol in Chinese population. Present study is an
attempt to correlate lipid profile of T2DM patients and evaluate the
association of the Apolipoprotein E gene and CAPN10 gene with
incidence of T2DM. The study design is a case control type in sub-
jects from different ethnic groups from the state of Rajasthan. The
polymorphisms in APOE and CAPN10 gene were detected by PCR–
RFLP. In all 80 patients and 89 healthy controls were grouped on the
basis of fasting blood glucose levels (FBG) and segregated according
to their BMI and WHR. No association was seen in diabetic cases and
controls for polymorphism in CAPN10 gene. A significant difference
was found for the presence of E*4 allele in females diabetic cases vs
control subjects (E*4 vs E*3 allele, Chi: 6.7, p \ 0.01, Odds Ratio:
2.968, CI: 1.1–1.8). The values for cholesterol and HDL were also
found to be significantly higher in diabetic patients with APOE*4
allele (p \ 0.05). The findings from the present study support a sig-
nificant role of APOE gene in the etiology of T2DM especially in
female subjects. Evaluation of different clinical and anthropometric
markers linked to T2DM and their association with APOE genotype
will also be presented.
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Evolutionarily conserved non-coding regions in human genome may
contribute to the regulation of the genes involved in the development
of complex diseases. Polymorphisms in these regions could exhibit
alternative effects on processes like transcription and splicing. We
have screened genetic variation in 16 conserved regions of a candi-
date gene for cardiovascular disease, SoLute Carrier family eight
(sodium/calcium exchanger), member one (SLC8A1). In rats, Slc8a1
has shown to play a role in the development salt-sensitive hyperten-
sion. In analyzing cardiovascular disease, patients from two European
populations, Estonians (essential hypertension) and Czech (coronary
artery disease), we found ten genetic variants (seven novel) located in
SLC8A1 conserved regions. We identified an intronic hypervariable
polymorphism presented in total nine alleles. The minor variants were
represented from singletons to allele frequencies 8.4%. We have
performed an association study of the most prevalent alternative
variant (a 14 bp insertion) with cardiovascular phenotypes (CAD, MI,
heart rate, intima media thickness), blood pressure traits (hyperten-
sion, SBP, DBP), and serum lipids. The indel was associated with the
incidence of CAD (logistic regression, additive model, p = 0.005)
and MI (p = 0.03), as well as with triglycerides (p = 0.02) and
intima media thickness (p = 0.03). The association with SBP and
DBP was detected under recessive genetic model.
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genome-wide scan with rheumatoid arthritis in Koreans
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A recent large-scale genome-wide association (GWA) screening for
seven common diseases by the Wellcome Trust Case Control Con-
sortium identified 11 single nucleotide polymorphisms (SNPs) for
rheumatoid arthritis (RA). In this study, their associations with RA
were tested with a Korean population of 1,313 RA-patients and 1,010
non-patient controls, who were genotyped for the 11 SNPs using the
MassARRAY iPLEX system. Among the 11 SNPs, only one SNP in
the HLA-class II region was significantly associated with RA sus-
ceptibility (P = 2.66 9 10-35) in Chi-square tests for allelic
association, and two SNPs (rs6679677 and rs6920220) were not
common in Koreans. In order to find new SNP markers covering
disease variants in both Asian and European populations, we calcu-
lated linkage disequilibrium values (r2) between the non-significant
SNPs and their neighboring SNPs using the International HapMap
Database and subtracted those in Asians (JPT + CHB) from those in
Caucasians (CEU). The ethnic difference in r2 between the two pop-
ulations was the largest for rs229484 and the GWA SNP rs743777 on
22q23 (r2 difference = 0.64). However, genotypes of rs229484 were
not significantly associated with RA (P = 0.096). Thus, all the ten
non-HLA SNPs would not be useful markers for RA susceptibility.
279: Polymorphisms in non-coding region of IFNG gene
and their association with atopic asthma
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Background: Interferon gamma (IFNc) regulates pathological features
such as airway inflammation, airway tissue remodeling etc., that are
characteristics of atopic asthma.
Objective: To investigate the association of IFNG gene polymor-
phisms with atopic asthma in Indian population and to elucidate their
functional significance.
Methods: Polymorphisms were identified using NCBI database and
sequencing 20 unrelated subjects. PCR, Snapshot and GeneScan were
used for further genotyping seven polymorphisms in IFNG gene, a
(CA)n repeat in intron one and six single nucleotide polymorphisms
[(rs2069705, T/C), (rs1861494, A/G), (rs1861493, T/C), (rs2069718,
C/T), (rs2069727, A/G) and (rs2069728, G/A)] in family and case-
control cohorts. Electrophoretic mobility shift assay was used to elu-
cidate the potential functional role of the SNPs.
Results: A significant association was obtained with A/G (rs18614934)
in case control (p = 0.0006) and family based (p = 0.006) association
studies. Also, a five locus haplotypic analysis showed significant
association with asthma in case-control (p = 0.002) and family based
studies (p = 0.0004). Moreover our results suggest that the region
encompassing the CA repeat, rs1861494A/G and rs2069718C/T is of
high priority with respect to asthma pathogenesis. Furthermore, we
demonstrate that the wild type allele (A) {A/G (rs18614934)} has
stronger affinity for nuclear factor(s) when compared to the polymor-
phic allele (G).
Conclusion: This study supports the role of IFNG gene polymorphism
in genetic susceptibility to asthma. Functional significance of the SNP
was partially demonstrated. Identification of the nuclear factor(s)
which bind to this locus might further improve our understanding of
the IFNG gene regulation and its role in asthma pathogenesis.
280: Physiological effect of human angiotensinogen
haplotypes on blood pressure in transgenic mice
Ashok Kumar
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Hypertension is a serious risk factor for myocardial infarction, heart
failure, vascular disease, stroke, and renal failure. The incidence of
hypertension and complications due to hypertension are even greater in
the African-American population. Angiotensinogen (AGT) gene locus
is associated with human essential hypertension and over-expression of
the AGT gene increases blood pressure in transgenic mice. There are
five polymorphic sites (A/G at -6, A/G at -217, T/C at -532, A/G at -793,
and T/G at -1,074) in 1.2 kb promoter of the human AGT gene. Variant -
217A almost always occurs with -532T, -793A, and -1074T and variant
-217G almost always occurs with -532C, -793G, and -1074G. Since
allele -6A is the predominant allele (frequency 0.85) in African–
Americans, this population can be subdivided into two major haplo-
types -6A: -217A (AA); -6A: -217G (AG. The frequency of AA
haplotype is significantly increased in African–American hypertensive
patients as compared to the AG haplotype. AGT gene is primarily
expressed in the liver and reporter constructs containing AA haplotype
of the AGT gene promoter have increased promoter activity on transient
transfection in human liver cells as compared to the AG haplotype. In
order to understand the role of AA and AG haplotypes on human AGT
expression in an in vivo situation, we have generated double transgenic
mice containing either haplotype AA or AG of the human AGT gene
using knock-in strategy at the HPRT locus and human renin gene. Our
quantitative RT-PCR analysis has shown that transgenic mice con-
taining AA haplotype have 1.6-fold increase in the AGT mRNA level in
the liver as compared to the transgenic mice containing AG haplotype.
In addition, Western blot analysis has shown that transgenic mice
containing AA haplotype have 30% increase in the AGT protein level in
the liver as compared to transgenic mice containing AG haplotype. In
addition we show that blood pressure of 3-months-old male transgenic
mice containing AA haplotype is increased by 7 mmHg during the day
time and 11 mMHg during the night time (n = 4 for 4 days) as com-
pared to the transgenic mice containing AG haplotype. To our
knowledge, this is the first report where polymorphisms in the promoter
of a human gene have been shown to have physiological affect in an in
vivo situation.
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metabolism pathway genes: association of CHDH
A119C and MTHFR C677T with
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The incidence of coronary artery disease (CAD) is increasing, espe-
cially in developing countries. In India, it has been predicted that
deaths due to CAD are likely to be more than any other disease. It is
often advocated that a vegetarian diet reduces the burden of CAD.
However, in India, where a significant proportion of the population
adheres to a vegetarian diet, the incidence of CAD is the highest. This
could be due to deficiency of vit.B12, an important micronutrient,
sourced only from animal products. Vitamin B12 deficiency can lead
to high levels of homocysteine (hcy), an independent risk factor for
cardiovascular disorder. We believe that in the background of vit. B12
deficiency, variations in genes involved in hcy metabolism will have
greater impact on hcy levels. In this study we genotyped 15 non
synonymous single nucleotide polymorphisms (nsSNPs) from eight
genes involved in hcy metabolism, in two phases, in an attempt to
identify the SNPs that are associated with hcy levels. We also
determined the basal frequency of these SNPs in Indian population as
a part of the Indian Genome Variation consortium. In the first phase,
these nsSNPs were genotyped in 546 individuals. Only two SNPs,
MTHFR C677T (p = 0.001) and CHDH A119C (p = 0.009) modu-
lated the levels of hcy. These two SNPs were then genotyped in an
additional 330 individuals. Even after increasing the sample size,
MTHFR C677T (p = 0.002) and CHDH A119C (p = 0.007) were
found to be significantly associated with hcy levels. Further, a three
way interaction between vegetarian diet and the two polymorphisms
was found to significantly elevate the levels of hcy (p = 0.04). We
also determined the basal frequencies of 13 SNPs in at least 24 sub-
populations spread across the country. We found that even amongst
the four Indian linguistic groups, Austro Asiatic (AA), Dravidian
(DR), Indo European (I.E) and Tibeto Burman (TB), the MAF varied
significantly between one or more groups in most of the cases. The
frequency of MTHFR 677TT genotype varied throughout the country
and in most (29/55) of the populations studied, TT genotype was
found to be absent. Interestingly, the TT genotype was present in all
the populations of North India (consisting of both I.E and TB lin-
guistic lineage). The risk genotype in choline dehydrogenase (CHDH
119AA) was uniformly distributed throughout the country although
the MAF was significantly higher in AA and TB populations as
compared to Indo European and Dravidian populations.
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Introduction: Hypertension and associated cardiovascular diseases,
alarmingly on rise in India are a global concern. The renin-angio-
tensin system (RAS) due to well-documented effects that influence
vascular tone, cardiovascular remodeling, salt and water homeostasis
and cardiovascular diseases has been a logical candidate for evalua-
tion in essential hypertension (EH). The key role of the gene products
of the RAS in regulation of blood pressure in humans strongly
motivates the study of the gene variants of this system.
Methods: we investigated the AGT G-6A (rs5051), T174M (rs4762)
and M235T (rs699) polymorphisms individually, in combination and
as haplotypes, and their correlation with related phenotypes including
systolic blood pressure (SBP), diastolic blood pressure (DBP), mean
blood pressure (MAP), plasma renin activity (PRA) and aldosterone
levels (PAC) for association with EH.
Results: The genotypes of G-6A and M235T polymorphisms differed
significantly between control and patient groups (P = 0.007,
OR = 1.9, 95% CI = 1.2–2.9; P \ 0.0001, OR = 3.7, 95% CI = 2.3–
5.7, respectively); as a consequence higher frequency of the -6A and
235T alleles was found in hypertensive patients (P \ 0.0001, each).
The GG174TT235MM genotypic combination reflected an OR of 0.43,
whereas the remaining genotypes combinations with minimum one to
more mutant variants amplified the risk of hypertension to 2.4 times
(P \ 0.0001). Besides, as the number of mutant alleles in a combination
increased, SBP, DBP and MAP increased (P \ 0.0001). It was also
observed that 2-locus A/174T, 174T/235T, A/235T and 3-locus
A/174T/235T and G/174T/235 M haplotypes served as hypertension
risk-predisposing haplotypes; whereas the haplotypes and diplotypes
holding -6G and 235M alleles were more frequent in controls and thus
these could be protective. Subsequently, hypertensive individuals had
higher PAC and ARR than controls, whereas controls showed higher
PRA than patients (P \ 0.0001, each) suggesting that the hypertensive
patients likely have low renin hypertension. The -6A and 235T alleles
correlated with significantly higher PAC (P \ 0.0001, respectively).
Conclusion: The -6A and 235T alleles and respective homozygous
genotypes were independently associated with hypertension suscep-
tibility. The interaction among G-6A, M235T and T174M
polymorphisms in combinations or haplotypes emerged significant.
These findings conjoint with significant high PAC and low PRA
suggest low renin hypertension in our study population.
283: Epidemiological, cytogenetic and molecular
approaches to decipher arsenic susceptibility
Manjari Kundu, Mayukh Banerjee, Pritha Ghosh,
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In West Bengal, although a large number of individuals are exposed
to arsenic through drinking water, yet, only less than 15–20% of total
arsenic exposed individuals showed arsenic induced skin lesions. So it
is assumed that genetic variations might play an important role in
arsenic induced toxicity and carcinogenicity. We have assessed the
arsenic induced health effects and genetic damage in the individuals
with and with out skin lesions exposed to same arsenic contaminated
water using a number of cytogenetic end points. Genetic and genomic
approaches have been adopted to decipher causes of arsenic suscep-
tibility. Comet assay and challenge assay were performed and single
nucleotide polymorphisms (SNPs) studies were carried out for a
number of genes that may involve the different pathways in arsenic
metabolism and detoxification. Results of DNA repair studies through
Challenge and Comet assay show that the individuals with arsenic
induced skin lesions had suboptimal DNA repair capacity. From the
GST’s group the homozygous null gene frequency of GSTT1 and
GSTM1 genes and SNPs of some other GST genes were also studied.
SNPs of TP53 gene, human purine nucleoside phosphorylase (PNP)
and ERCC2 genes were also analyses. Distribution of homozygous
GSTM1 null genotype was significantly higher in the no skin lesions
group indicating a protective role of GSTM1 null in the no skin
lesions individuals. On the other hand the individuals with TP53
codon 72 Arg/Arg genotype is over represented in the skin lesions
individuals indicating that this genotype is more susceptible to arsenic
induced toxicity. Lys/Lys genotype in the ERCC2 polymorphism was
almost five fold over represented in the arsenic induced hyperkera-
tosis skin lesions group when compared to no skin lesions group. We
also showed that risk genotypes of ERCC2 and TP53 SNPs were
positively correlated to genetic damage in having significantly higher
chromosomal aberrations compared to the referent genotypes. Thus
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the above results indicate that the sub-optimal DNA repair and the
genetic variations are responsible for arsenic induced toxicity and
carcinogenicity.
284: Association of Apolipoprotein A4 polymorphisms
Asn147Ser and Thr347Ser with type 2 diabetes
in an Asian Indian population
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Aim: The APOA4 gene has been implicated in the development of
dyslipidemia in Type 2 diabetes patients. The objectives of the
present investigation was to examine the relationship of two poly-
morphisms located in the exon 3 of the Apolipoprotein A4 gene
(APOA4), Asn (N) 147Ser(S), A [ G (rs 5104) and Thr(T)
347Ser(S), A [ T(rs 675) in the Asian Indian population.
Methods: The study group comprised of 762 type 2 diabetes and 536
Normal Glucose Tolerant (NGT) subjects chosen from the Chennai
Urban Rural Epidemiological Study, an ongoing population-based
study in Southern India. The two polymorphisms were genotype using
PCR–RFLP method and confirmed by direct sequencing. The geno-
type frequencies were estimated by using Chi-square analysis. The
Odds ratio was estimated using Logistic regression Analysis from
SPSS Version 10.0.
Results: 62% of the type 2 diabetes patients had the Asn/Ser genotype
compared with 53.8% of Normal Glucose Tolerant subjects (NGT),
p = 0.01. Logistic regression analysis of the Asn147 Ser polymor-
phism showed the odds ratio (adjusted for age, body mass index
[BMI]) was 1.62 (95% CI: 1.92–2.22, p = 0.002) for the Asn/Ser
genotype when compared with the Asn/Asn genotype. In case of the
Thr347Ser polymorphism, 27.2% of the type 2 diabetes has Thr/Ser
genotype when compared with 35.6% of the Normal glucose Tolerant
subjects (NGT), p = 0.01 showing a protective effect towards type 2
diabetes. Logistic regression analysis of the Thr 347 Ser polymor-
phism showed the odds ratio (adjusted for age, BMI) was 0.606 (95%
CI: 0.451–0.815, p = 0.001) for the Thr/Ser genotype when com-
pared with the Thr/Thr genotype.
Conclusions: The two polymorphisms, Asn147Ser and Thr347Ser
were associated with Type 2 Diabetes in Asian Indian subjects. The
Asn/Ser genotype of the Asn147Ser polymorphism confers 1.62 times
higher risk for type 2 diabetes, whereas the Thr/Ser genotype of the
Thr347Ser polymorphism confers 0.606 times lower risk for devel-
oping type 2 diabetes in this population.
285: Genome-wide association study with blood
pressure traits
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Hypertension is a common disease affecting 25% of the adult popu-
lation. Different studies have suggested that approximately 33–66%
of the inter-individual variance in BP level is heritable. In order to
search for novel genetic variants associated with BP levels, we con-
ducted a genome-wide association study (GWAS) for three blood
pressure traits (SBP, DBP and HYP) in the KORA (Kooperative
Gesundheitsforschung in der Region Augsburg) S3/F3 epidemiolog-
ical cohort (n = 1,644) recruited from a general population in
Southern-Germany. Using a three stage study design, we identified
two new loci (at 16q23 and 17p13) associated with BP traits and
replicated these associations in two European populations (Germans,
Estonians). In a third population (British) we obtained consistent
effect signs but borderline P values. The minor variants of these SNPs
reduce BP and therefore, protect from the development of hyperten-
sion (joint analysis, n = 1,900 hypertensives/4,365 normotensives:
P = 5.41 9 10-8, OR = 0.73 and P = 7.42 9 10-7, OR = 0.65,
respectively). The identification of two novel loci encourages further
research to clarify the functional basis of the identified associations.
286: Identification of unique primary and secondary
Glioblastoma Multiforme (GBM) specific networks
and molecular connections using protein–protein
interaction tools
1Jayashree Ladha, 2Shipra Agrawal, 1Sainitin Donakonda,
1M. R. S. Rao
1Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for
Advanced Scientific Research, Jakkur, Bangalore, India, 2Institute of
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Gliomas of astrocytic origin have been classified by WHO into
tumors that arise de novo (primary GBM) and those that manifest
progression from a low grade tumor to a highly invasive, metastatic
type (secondary GBM). These clinical differences are also accom-
panied by a set of distinct molecular and genetic abnormalities. EGFR
amplification and PTEN deletions are hallmarks of primary GBM,
whereas TP53 and PDGFRB mutations are common to secondary
GBM. The advent and extensive use of high throughput genomic and
proteomic tools on a genome wide level allows individual’s gene
expression to be analyzed on a global scale. Early exercises of these
tools have delineated several cellular perturbations associated with
oncogenesis. Recently a combinatorial approach of differentially
regulated genes and protein interaction network of these gene prod-
ucts have provided valuable information of molecular connections in
different pathways which go awry in the diseased condition. We have
used this approach to construct cellular network characteristic of
primary and secondary GBM and identified novel molecular con-
nections in these two types of GBM. Clinically and experimentally
validated genes that showed specific up regulated expression pattern
in primary and secondary glioblastoma (58 and 22 genes respectively)
were used as the input and subjected to Systems biology analysis to
construct molecular interaction network of proteins using APID
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interaction database and Cytoscape software. This generated a com-
piled molecular network of primary and secondary GBM specific
proteins. Careful dissection of the functional modules, important
nodes and connections allowed identification novel intermediary
molecules (5 in primary and 2 in secondary GBM network) that have
potential to be assessed for their relevance in gliomagenesis and
prognostication. These genes are functionally important centered
around the biological processes such as signaling by tyrosine kinase
receptors, extracellular matrix remodeling and cell proliferation in
primary GBM and around cell cycle regulation, apoptosis and evasion
of immune response in secondary GBM. These molecules can be
combined with the existing molecular signatures to predict the out-
come of glioma and can also be compared with other forms of glial
disorders to differentiate between confusing tumors types by com-
bining mutational and epigenetic information.
287: Somatic DNA amplification as a phenotype
in cancer
1Thomas LaFramboise, 1Cheryl Thompson, 2Itsik Pe’er,
3Matthew Freedman
1Case Western Reserve University, Cleveland, OH, USA, 2Columbia
University, New York, NY, USA, 3The Broad Institute of Harvard
and MIT, Cambridge, MA, USA
Cancer is known to have a complex etiology, with both inherited and
somatic components. Recent studies have yielded promising results
using SNPs as markers in associations studies, detecting associations
between certain SNP alleles and susceptibility to a variety of cancer
types. However, bearing in mind that somatic copy number changes
are a hallmark of cancer, we have conducted a study treating somatic
copy number lesions (representing the cancer genome) at each gene
as an phenotype, with inherited SNP alleles (representing the
germline genome) as predictors. We have analyzed 474 lung and
breast cancer samples. For each of these samples, we possess Af-
fymetrix 250K SNP array data for both tumor DNA and matched
normal DNA. Our analysis reveals abundant cis associations between
inherited variants and somatic amplification of certain genes,
including well-known oncogenes. We also report some evidence for
trans associations. This study demonstrates that somatic amplification
may be treated as an intermediary molecular phenotype in cancer,
and that the germline genome and tumor genome may be simulta-
neously interrogated in the patient to gain additional insight into
inherited cancer susceptibility.
288: A comprehensive approach towards analysis
of complex disorders: Tropical calcific pancreatitis
as a model
1,2Swapna Mahurkar, 1Seema Bhaskar, 1K. Radha Mani,
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Chronic pancreatitis (CP) is an inflammatory disease of pancreas
characterized by irreversible destruction of exocrine mass and pro-
gressive endocrine failure leading to pancreatic insufficiency and
diabetes. It has been proposed that CP occurs due to activation of
trypsinogen within pancreas before being secreted into the duodenum.
A non-alcoholic type of juvenile and severe form of CP with uncer-
tain etiology, specific to tropics is known as tropical calcific
pancreatitis (TCP). We established the genetic basis of TCP and
showed it to be different from the West. A founder mutation N34S in
SPINK1 gene was detected in majority of patients in contrast to
cationic trypsinogen mutations in Caucasians. To understand the
etiopathology of TCP a comprehensive study on genomic and pro-
teomic front was designed. Several candidate genes were screened for
associated variants, hypothesizing their role in the initiation of pan-
creatitis by gain of function mutations leading to premature activation
of trypsinogen. Variants in the signal peptide region of cathepsin B
(CTSB) were found to be associated with TCP and proposed to be the
second candidate gene. No association was seen with genes such as
anionic trypsinogen (PRSS2), Transcription factor 7 like 2 (TCF7L2)
and regenerating islet-derived protein 1a (REG1A) selected for their
role in causation of exocrine damage, diabetes and stone formation,
respectively. As there are no reports on systematic study of gene
expression in CP patients, we conducted microarray analysis using
cDNA and oligonucleotide (Affymetrix) platforms on pancreatic tis-
sue samples from TCP patients and normal individuals as per
International guidelines and identified several genes to be differen-
tially regulated. Classification of genes based on Gene Ontology
descriptions revealed down-regulation of genes coding various
digestive enzymes corroborating various clinical features of TCP.
Pathway analysis revealed pathways like cell adhesion molecules
(CAM), inositol 1,4,5-triphosphate receptor (IP3R), Mitogen acti-
vated protein kinase (MAPK), etc., to be involved, suggesting an
ongoing apoptosis and necrosis in the patient tissue. Real-Time PCR
on selected genes validated the results obtained from microarray
experiments. Proteomic profile of the pancreatic tissues from these
patients identified about 35 differentially regulated proteins. Finally,
through systems biology approach, we attempted to network vari-
ous genetic and non-genetic factors involved in the pathogenesis of
TCP.
289: Association of the pituitary growth hormone
and its receptor gene polymorphisms with premature
coronary artery disease in Asian Indians
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In view of the inadequacy of our knowledge, till date, on the exact
number of genes and the quantum of their effect on the etiopathology
of cardiovascular disease (CVD), it becomes imperative that further
investigations on novel genetic risk factors are conducted on the
predisposed yet previously untested populations like the Asian Indi-
ans. The present study was undertaken to investigate the putative
association of the polymorphisms in the pituitary growth hormone
(GH1) and its receptor (GHR) genes with premature coronary artery
disease (CAD), the most common form of CVD, in Asian Indians.
The study participants, selected from the ongoing Indian Athero-
sclerosis Research Study (IARS), consisted of 178 patients of
premature CAD and 151 healthy controls. Sequencing of the promoter
region of the GH1 gene revealed 8 novel sequence variants in our
cohort. An AGA promoter haplotype was found to be significantly
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associated with CAD. The unadjusted and the adjusted odds ratio
(OR) after correction for age, gender, diabetes and hypertension were
estimated to be 2.64 (95% CI: 1.24, 5.6, p = 0.012) and 3.77 (95%
CI: 1.35, 10.50, p = 0.012), respectively, for this association. The
presence of the exon 3 deletion in the growth hormone receptor gene
(GHRd3) was detected and quantitated by real time PCR assays. The
absence of GHRd3 was found to be significantly associated with CAD
in patients with a history of hypertension (p = 0.018). The data
supported a dominant genetic model for GHRd3 allele with unad-
justed and adjusted OR of 0.51 (95% CI: 0.29, 0.90, p = 0.018) and
0.40 (95% CI: 0.19, 0.85, p = 0.014), respectively, after correction
for age, gender and diabetes. Our results implicate GH1 and GHRd3
polymorphisms in premature CAD in Asian Indians. These novel
findings might help in opening new avenues towards understanding of
cardiovascular disease biology from the perspective of growth and
development as well as assist in the evolution of important markers
for the early detection of genetic predisposition to CAD.
290: Association of Xenobiotic metabolizing enzymes
genetic polymorphisms with esophageal and gastric
cancers in Kashmir valley: Influence of smoking
and consumption of salted tea
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Introduction: Xenobiotic metabolizing enzymes are involved in the
detoxification of many potential carcinogens and appear to play a
critical role in the protection from the effects of carcinogens. Kashmir
valley has elevated incidence rate of esophageal (EC) and gastric
(GC) cancers. Several environmental and host genetic factors have
been suspected for development of EC and GC. Therefore, this study
was performed to assess the association of genetic variants of xeno-
biotic metabolizing enzyme genes with susceptibility of esophageal
and gastric cancers in Kashmir valley.
Methods: A case control study was performed in 381 subjects (108 EC,
72 GC and 201 healthy subjects) to analyze association of polymor-
phisms in GSTM1null, GSTT1null, GSTP1 313ile/val, GSTM3 intron6
3 bp deletion,CYP1A1 6235T [ C and CYP2E1Rsa1-1091C [ T
genes with susceptibility of EC and GC as well as their interaction with
smoking and high consumption of salted tea. All subjects were geno-
typed through PCR/PCR–RFLP. Data was analyzed using chi-square
test and logistic regression model.
Results: GSTP1313 val/val and CYP2E1c1c2 genotypes imparted risk
for EC (OR = 2.966, P = 0.034; OR = 2.802, P = 0.015) while
individuals with GSTT1null and CYP2E1c1c2 genotype were at higher
risk of GC (OR = 2.492, P = 0.044; OR = 2.015, P = 0.032).
Smokers were at higher risk for developing EC and GC (OR = 21.465,
P = 0.0001; OR = 16.338, P = 0.0001). Similarly, higher consump-
tion of salted tea was also associated with increased risk of EC and GC
(OR = 18.179, P = 0.001; OR = 16.338, P = 0.0001). Smokers with
GSTT1null and high salted tea consumers with GSTM1null genotypes
were at increased risk for GC development (OR = 3.213, P = 0.047;
OR = 18.535, P = 0.009).
Conclusions: GSTP1 val/val, GSTM3AB and CYP2E1c1c2 genotypes
modulate risk of EC; while GSTT1null and CYP2E1c1c2 genotypes
impart risk for GC. GSTT1null and GSTM1null genotypes enhance
risk of GC in smokers and high salted tea consumers in Kashmir.
Acknowledgment: The study was supported by a research grant from
Indian Council of Medical Research, New Delhi.
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Aim: To map genes that control ten quantitative precursors of coro-
nary artery disease (CAD), with the overarching goal of genomic
dissection of CAD. The quantitative traits (QTs) selected were apo-
lipoprotein B [ApoB], C-reactive protein [CRP], fibrinogen [FIB],
homocysteine [HCY], lipoprotein a [Lp(a)], total cholesterol [CHOL-
T], HDL-cholesterol [CHOL-H], LDL-cholesterol [CHOL-L],
VLDL-cholesterol [CHOL-V] and triglyceride [TG].
Methodology: We focused on an isolated population—Marwari,
known to have a high prevalence of CAD. Members (n = 459) of
45 extended families, each ascertained through the presence of at
least two first-degree relatives with CAD were recruited. A total of
209 SNPs in 31 genes selected from a relevant biochemical pathway
were assayed. From the family data, a subset of 155 unrelated
individuals was identified. After adjusting for demographic,
anthropometric, life-style and behavioral variables, using a stepwise
regression analysis, ANOVA was performed to test the equality of
mean values of adjusted QTs among genotypes at each SNP locus.
For each locus for which statistically significant difference was
detected for any QT, a quantitative transmission-disequilibrium test
(qTDT) was performed using data on nuclear families (327 indi-
viduals in 144 families).
Results: Statistically significant results found, on the basis of ANOVA
and qTDT analyses, for the various QTs and SNPs were: (1) ApoB with
NFKB1: rs230521 (Intronic) ANOVA p-value (p) = 0.007, qTDT p-
value (p*) = 0.024; and, rs1005819 (Intronic) p = 0.01, p* = 0.02.
(2) FIB with NFKB1: rs4648004 (Intronic) p = 0.04, p* = 0.002. (3)
FIB with FGB: rs4220 (Missense, K [ R) p = 0.009, p* = 0.04, (4)
Lp(a) with SCARB1: rs4765180 (Intronic) p = 0.02, p* = 0.01. (5)
CHOL-H with SELE: rs5361 (Missense, R [ S) p = 0.01, p* = 0.03.
(6) CHOL-H with MYD88: rs7744 (30UTR) p = 0.02, p* = 0.04. (7)
CHOL-V with SELP: rs3917744 (Intronic) p = 0.02, p* = 0.005. (8)
CHOL-V with CD14: rs4914 (Synonymous) p = 0.002, p* = 0.04. No
statistically significant results were found for CRP, HCY, CHOL-T,
CHOL-L and TG.
Conclusion: SELE, SELP, CD14, MYD88, SCARB1, FGB and NFKB1
are genes that impact on levels of quantitative precursors of CAD in
Marwaris. The K [ R change in FGB increases fibrinogen level. The
R [ S change in SELE is ‘damaging’ (SIFT score = 0.01) and
increases thrombin generation. Higher density saturation studies are
required to identify causal SNPs that may be in linkage disequilibrium
with the remaining 7 SNPs.
292: CYP17A1 (T-34C), CYP19A1 (Trp39Arg),
and FGFR2 (C-906T) polymorphisms and the risk
of breast cancer in South Indian women population
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Breast Cancer is initiated by exposure to endogenous and exogenous
estrogens. Genes involved in biosynthesis of estrogens and growth
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factor receptors play an important role in breast cancer development.
A case (n = 250)—control (n = 500) study was undertaken to
investigate the role of Single Nucleotide Polymorphisms (SNP’s) in
CYP17A1 (T-34C), CYP19A1 (Trp39Arg) and FGFR2(C-906T).
Genotyping was done using Taqman Allelic discrimination assay for
CYP17A1 (T-34C) and FGFR2 (C-906T) and PCR-CTPP for
CYP19A1 (Trp39Arg). There was a significant association of het-
erozygous (TT/CC) genotype of CYP17A1 gene with the risk of
developing breast cancer (OR = 0.68, 95% CI: 0.49–0.96). And the
same genotype of the CYP17A1 gene was significantly associated
with deceased risk in postmenopausal women (OR = 0.56, 95% CI:
0.35–0.89) (p = 0.015). CYP19A1 (Trp39Arg) is a rare polymor-
phism, all the cases were homozygous for wild type Trp allele
(100%); in controls 99.2% were homozygous for wild type and 0.8%
was heterozygous. We are unable to detect the variant form of the
CYP19A1 gene in south Indian women population. There was no
significant association between the risk of breast cancer and FGFR2
(C-906T), which is supposed to be a newly identified gene linked with
breast cancer incidence in western population. These results suggest
that CYP17A1 TT/CC genotype was associated with decreased risk
for breast cancer especially in post menopausal women. CYP19A1
(Trp39Arg) and FGFR2 (C-906T) have no role to play with breast
cancer risk in South Indian women population, further studies with
more cases and control are needed to evaluate the role of these genes
risk in South Indian women population.
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Leigh syndrome is a progressive neuro-metabolic mitochondrial dis-
order usually presenting in infancy or early childhood with varied
clinical features and evidence of genetic heterogeneity. Leigh syn-
drome in India has hardly been explored and hence, we attempted to
understand its clinical, biochemical, imageological, and genetic basis
in 165 patients from South India. All the patients were infants, pre-
sented in acute life threatening condition and responded dramatically
towards thiamine supplementation. Electron microscopic and histo-
chemical analyses revealed the structural and functional defects in
mitochondria. All the investigations, suggested a different phenotype
of Leigh syndrome in Indians.
To investigate the genetic basis of this phenotype, complete
mitochondrial genome and nuclear genes encoding components of
respiratory complexes were screened in the patients and 94 normal
infants. Based on bioinformatics analysis using Clustal W, SIFT and
PolyPhen, seven mutations in different genes were investigated using
in vitro assays to understand likely mechanism responsible for the
phenotype. Effect of mitochondrial mutations were analysed by
generating cybrids while SURF1 mutations were analyzed using wild
and mutant SURF1 cDNA constructs followed by preparation of
stable clone in COS-7 cells. Two mutations, G6036A (G45S) in MT-
CO2, found in three patients and (exon 9, C [ T) P298L in SURF1,
present in 6 patients were predicted to affect the conserved residues
and affect the stereochemical property of the protein. Both mutations
showed *50% decrease in Complex IV activity suggesting that
defect in complex IV may be one of the major causes for such a
phenotype. Since majority of patients responded to thiamine supple-
mentation, estimation and comparison of thiamine level in blood
samples of patients and randomly selected normal individuals from
same geographical region suggested that thiamine deficiency alone
could not cause the disease but may add to the severity of the phe-
notype. To conclude, our study involving the largest cohort of LS
patients gives an idea about the atypical presentation of Leigh Syn-
drome patients in Indian population and shows a variable genetic
basis. It also suggests that thiamine deficiency could be an additional
factor, influencing the phenotype in the presence of genetic abnor-
mality. In addition, it also alerts the clinicians towards the importance
of thiamine supplementation for such a phenotype, as timely thiamine
supplementation can save several precious lives.
294: Multiple HLA-DR3 haplotypes associated
with autoimmunity in North Indians
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The aim of the study was to define HLA-DR3 positive extended
haplotypes associated with susceptibility to Type 1 diabetes in North
India. We evaluated multiple SNPs and microsatellites located
between HLA-A and DQB1 locus in the MHC region in 145 North
Indian T1D patients. The MHC halotypes were deduced from family
pedigrees and compared with those prevalent in healthy Indian pop-
ulation. A comparison of frequencies of HLA class I alleles among
T1D patients and healthy controls showed a significant increase in
HLA-A*02, A*26, B*08, B*50 and B*58 in the patient group.
Similarly, analyses of class II genes revealed a strong association of
DR3-DQ2 among the patients (75.9% vs. 14.6% in controls, p = 7.53
E-11). Further molecular analyses revealed that there are multiple
DRB1*03 positive haplotypes (predominantly B8-DR3, B50-DR3
and B58-DR3) that are associated with T1D in the Indian population.
These haplotypes differ significantly from the classical Caucasian
AH8.1 (HLA-A1-B8-DR3), associated with several autoimmune
diseases. The Caucasian AH8.1 is rare in the Indian population and
has been replaced by a variant AH8.1v and other DR3 positive hap-
lotypes, A26-B8-DR3 (AH8.2), HLA-A24-B8-DR3 (AH8.3), A3-B8-
DR3 (AH8.4), A31-B8-DR3 (AH8.5), A2-B8-DR3 (AH8.6), A11-B8-
DR3 (AH8.7) and A33-B8-DR3 (AH8.8). Among these, the AH8.2 is
the most common haplotype and represents 43% of the total B8-DR3
haplotypes in this population. The Indian B8-DR3 haplotypes differ
significantly from Caucasian AH8.1 at multiple loci. For example,
the Indian haplotypes have HLA-Cw*0702, HLA-DRB3*0202,
HSP70-21267A, TNFA-308G, TNFa 105, Bf-F, C4A-1, MIB 352 as
compared to Caucasian HLA-Cw*0701, HLA-DRB3*0101, HSP70-
21267G, TNFA-308A, TNFa 99, Bf-S, C4A-0, MIB 350. These dif-
ferences suggest that B8-DR3-DQ2 haplotypes in the Asian Indian
population might have originated independently of Caucasian AH8.1
selectively through recombination and multiple mutations. Among
these B8-DR3 haplotypes, a significant association of AH8.2
(p = 2.91 E-06), AH8.3 (p = 2.01 E-05) and AH8.6 (p = 1.13 E-07)
was observed with T1D. These findings have important implications
in understanding disease associations along with their evolutionary
significance.
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with Familial Adenomatouos Polyposis (FAP)
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Colorectal cancer has been recognized as one of the more common
causes of early death due to malignancy worldwide. About 20% of all
colon cancer cases are thought to be hereditary. Two well defined
forms of hereditary colon cancer are familial adenomatous polyposis
coli (FAP) and hereditary non-polyposis colon cancer (HNPCC).
Germline mutations in the tumour-suppressor APC gene, localized on
5q in 1991, are associated with FAP. The vast majority of these
mutations are nonsense or frameshifts resulting in non-functional,
truncated APC protein products.
The present study was carried out to characterize the causative
genetic mutation in several medium sized Malaysian families affected
with FAP. Mutation screening was performed using the SSCP anal-
ysis technique, after which the exons showing mobility shifts (variant
bands) were sequenced to determine the nature of the sequence
change. SSCP results showed mobility shifts various exon, including
8, 11, 13 and 15. Sequence analysis revealed polymorphisms (exon
15) and patient specific mutations (in exons 11, 13 and 15) which
have proved valuable for presymptomatic diagnosis of at-risk family
members.
296: Gene expression profiling of the hepatic
transcriptome in the presence of TNF a
Neha Munjal, Amit Pandey, Malabika Datta
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Diabetes mellitus, often simply termed Diabetes, is a syndrome
characterized by disordered metabolism and high blood sugar. It is
caused due to low levels of insulin hormone or from abnormal
resistance to insulin in its target tissues. World Health Organization
estimates that India will alone have 79.4 million diabetic patients in
2,030. One of its major form Type 2 diabetes, is often associated with
obesity, hypertension, elevated cholesterol and metabolic syndrome.
Changes in life style, such as consumption of high-calorie diet and
lack of exercise, have increased the global prevalence not only of
diabetes but also of obesity. Type 2 diabetes is characterized by
insulin resistance in target tissue, occurs due to several reasons and
one of them being the proinflammatory cytokine, TNFa. It is also
known as the link between diabetes and obesity. High levels of TNFa
interfere with insulin signaling to cause the effect and to further
investigate into the situation, gene transcription profiling was exam-
ined in control and TNFa treated HepG2 cells. Results indicated that
TNFa could significantly alter the expression of a significant number
of genes that were identified to be related to lipid and fat metabolism
on one hand and to immunoglobulin receptor activity and IgE binding
thereby on the other thereby indicating global dysregulation of fat
metabolism and compromise in immune defense mechanism(s) within
the hepatocyte by TNFa. Pathway analysis revealed ‘biosynthesis of
steroids’ to be most effected. All these indicate TNFa to be signifi-
cantly altering the transcriptome profiling within HepG2 cells with
genes involved in lipid and steroid metabolism being the most
favoured and this could explain one of the underlying mechanisms of
TNFa action in the liver.
297: Differentially expressed transcripts in the adipose
tissue of ‘sumo rats’ (WNIN/Ob)
Srivani Muthuswamy, Sudip Ghosh, N. V. Giridharan,
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Hyderabad, 500007, India
The etiology of obesity and associated disorders involve very com-
plex gene–gene and gene–environment interactions, making it a
formidable challenge to study their molecular mechanisms in human.
Therefore, the best way to study the pathophysiology of these dis-
orders is to employ various animal models of genetic and non-genetic
animal models of obesity. A rat model of obesity has been developed
at the National Institute Nutrition, Hyderabad. These ‘sumo rats’
(WNIN/Ob), originally identified from an inbred Wistar rat line,
attain bodyweight more than twice of their lean littermates, are also
hyperphagic, euglucaemic. They also show hyperinsulinaemia, hy-
pertrigleridaemia and hypercholerolaemia characteristic to human
obesity. To identify the transcripts that are over or under expressed in
the adipose tissue of these rats, we carried out forward and reverse
subtraction hybridization PCR using the RNA isolated from the adi-
pose tissue of the sumo rats and their lean littermates. Genes
identified to be overexpressed in the adiopose tissue of these obese
rats include members from a wide range of gene families like lipid
and carbohydrate metabolism, electrolyte transporters, general and
specific transcription factors, signal transducers etc. Some of these
genes were previously known to be over expressed in obesity whereas
others are so far not implicated in the development of obesity.
Functional characterization of these genes are in progress using
siRNA and transient over expression studies.
298: Attenuation of hepatic insulin sensitivity by TNFa
Amit K. Pandey, Gaurav Verma, Malabika Datta
Institute of Genomics and Integrative Biology, Mall Road,
Delhi 110 007, India
Type 2 diabetes is almost invariably associated with obesity and the
adipose tissue that was originally identified as an inert storage organ,
is now appropriately classified as an endocrine organ. Several factors
have been identified as being released from the adipocytes and their
circulatory levels have been found to correlate proportionately to the
adipocyte mass and the associated status of insulin resistance. Tumor
necrosis factor alpha (TNF-alpha) is one such factor that is increased
under these conditions and it inhibits insulin signaling by interfering
at several points of the signaling cascade. Of the several insulin target
tissues, the liver is critical in maintaining circulatory glucose levels
through hepatic glucose output and alterations in this phenomenon
aggravates an already existing hyperglycemic status as observed in
obese diabetics. Using the human hepatoma (HepG2) cell line, we
studied the role of TNF alpha in the regulation of this pathway and
determined the molecular mechanisms underlying the effect(s) of
TNF-alpha in insulin action on hepatic gluconeogenesis. TNF-alpha
significantly attenuated insulin induced inhibition of the expression of
gluconeogenic enzymes and hepatic glucose production. Since the
transcription factor, Foxa2 has in part been implicated in the regu-
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lation of gluconeogenic gene’s transcription, we studied the effects of
TNF-alpha and/or insulin on its cellular status in the hepatocyte.
Preincubation of HepG2 cells with TNF-alpha followed by insulin
significantly narrowed down insulin mediated exclusion of Foxa2
from the nucleus thereby substantially increasing its nuclear con-
centration and this possibly is responsible for the varied effects on
gluconeogenesis and hepatic glucose output. TNF-alpha thus signifi-
cantly abrogates insulin signaling in HepG2 cells leading to an
increased nuclear presence of Foxa2 and subsequent elevated
expression of gluconeogenic gene and glucose production. These
results explain one of the mechanisms behind unrestrained hepatic
glucose output that exaggerates an existing hyperglycemic status as
observed in diabetic individuals.
299: Balancing the role of gene and environment:
High-altitude adaptation and mal-adaptation
1M. A. Qadar Pasha, 1Tsering Stobdan, 2Tsering Norboo,
3Gulam Mohammad, 3Mohammad Iqbal, 3Tashi Thinles
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High-altitude (HA) adaptation/mal-adaptation is a multifactor trait to
which genetic and environmental factors contribute interactively. The
traditional candidate gene approach for identifying molecular variants
having functional role and associating with HA adaptation and dis-
orders such as High-altitude pulmonary edema (HAPE) have achieved
considerable success in elucidating individual’s susceptibility. Iden-
tification of candidate genes still poses a great challenge. Since at HA,
the adaptation/mal-adaptation is mainly characterized by induced
pulmonary vasoconstriction, endothelial dysfunction and intra-vas-
cular fluid retention, the genes involved in maintaining pulmonary
vascular tone could be possible candidates. In a comparative study of
highland (HL), lowland (LL) natives, and case-control i.e., HAPE
patients-HAPE resistant sojourners, we investigated the polymor-
phisms insertion/deletion (I/D) (GenBank accession no X62855) of
ACE, G-6A (rs5049); T174 M (rs4762) and M235T (rs699) of AGT;
the G894T (rs1799983), 27 base pair 4b/4a (Ensembl Gene ID-
ENSG00000164867), -922 A/G (rs1800779) and -786 T/C
(rs3918161) of NOS3; the -344T/C (rs1799998), intron-2 conversion
(Iw/Ic) (NCBI accession No. NW_924018) and Lys173Arg (rs4539)
of CYP11B2 and (CT)n-(CA)n repeat (GenBank accession No.
J05008), -3A/-4A (rs10478694), G2288T (rs2070699) and
Lys198Asn (rs5370) of EDN1. Individual allele/genotype, combina-
tions of genotypes, haplotypes, gene–gene interactions and relevant
biomarkers were analyzed.
The allele/genotype distribution at the same locus varied signifi-
cantly between different groups. The I, 894G and 4b, 2288G and
longer repeats of -3A/-4A, and -344T allele frequencies were higher
in HL than the LL (p \ 0.05). Whereas, over-representation of D,
894T and 4a, 2288T and the Ic alleles was obtained in the HAPE-
patients (p between 0.03 and 0.002) when compared against the
HAPE-resistant controls. Combinations of genotypes analysis
revealed over-representation of GGbb of NOS3, II/GG of ACE/END1
and the six/five major alleles of CYP11B2 in the controls and a
reverse trend in the patients (p \ 0.05). The higher ACE activity,
endothelin and aldosterone levels and lower NO levels correlated with
respective variants (p \ 0.0001). A particular genetic setup of vas-
cular homeostasis system in sojourners may help them cope with
adverse HA environment and could ultimately be identified to pre-
dispose to adaptation and maladaptation.
300: Association of insertion deletion polymorphism
in intron 16 of ACE gene with essential hypertension
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Several gene polymorphisms have been reported to be possible
determinants of Hypertension of which the Angiotensin Converting
Enzyme (ACE) that converts Angiotensin I to Angiotensin II, plays an
important role in the elevation of blood pressure. ACE is a zinc
metalloprotase containing two functional domains. ACE gene is
located on chromosome 17q-23 and has 26 exons spanning 21 kb and
is associated with vascular diseases. There is an Insertion/Deletion (I/
D) of 287 bp in the intron-16 of the gene which shows polymorphism.
The present study focuses on the risk conferred by I/D polymorphism
for hypertension. The distribution of demographic parameters in 179
cases studied revealed a higher percentage of males (52.5%) when
compared to females. The proportion of smokers was 20.67% and
alcoholics 35.19%. There was a higher frequency of non-vegetarians
among the hypertensives (81.56%). The frequency of familial history
was higher in cases (55.86%) as compared to controls (40.8%). The
age of onset of hypertension among patients varied from 35 to
60 years with a modal class of 40–50 years. The early age of onset of
hypertension (\40 years) was recorded in 21.22% hypertensive
patients. The frequency of obese subjects (BMI [ 30) was twice
(13.96%) in hypertensives as compared to controls (6.25%). The
distribution of I/D genotypes revealed greater I/I genotype (37.03%)
in cases (n = 108) when compared to controls (27.17%) (n = 92).
Between the sexes, female hypertensives showed a higher percentage
of I/I genotype (47.82%) when compared to male hypertensives
(29.03%). Among the alcoholics a significant deviation (v = 8.08;
p \ 0.017) was observed within the cases. A significant deviation of
I/I and D/D genotypes was observed in the females between the cases
and controls (v = 11.6; p \ 0.002). The odds ratio computed for
genotypic combinations and alleles did not reveal any significant
results. The study has to be substantiated with larger sample size.
301: Genetic predisposition to DNA repair
and its effects on tumor response to radiation therapy
in oral cancer
1Surya Ramachandran, 2Ramdas Kunnambath,
1M. Radhakrishna Pillai
1Translational Cancer Research Laboratory, Rajiv Gandhi Center for
Biotechnology, Thycaud PO, Thiruvananthapuram, India, 2Head and
Neck Specialty Clinic, Regional Cancer Center, Medical college PO,
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Individuals differ in their susceptibility to disease. Some of these
differences are attributed to the concept that heritable traits modify
the effects of environmental exposures. Cancer of the oral cavity
epitomizes this concept. Oral cancer, the eight most common
malignancy and a major cause of cancer morbidity and mortality
worldwide has become a significant social and economic burden in
parts of South East Asia, particularly India. More than 80% of oral
cancers are attributed to tobacco. However, only a fraction of smokers
acquire oral cancer in their lifetime. One of the several cellular pro-
cesses that could explain this inter-individual variation in risk is DNA
Repair Capacity (DRC), which has been the focus of our study. There
is a large subgroup with reduced DRC who are likely to be at
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increased cancer risk, but are phenotypically normal. Our approach to
risk assessment has been multitiered, beginning with a detailed epi-
demiological assessment in case-control studies, followed by the
application of phenotypic and genotypic markers of genetic suscep-
tibility. We first observed that SNPs in major DNA repair genes like
XRCC1, XRCC3, ERCC1 and ERCC2 played a major role in pre-
dicting genetic susceptibility to oral cancer. We then looked into the
actual extent of DNA damage, established by our in vitro studies
using the Cytokinesis Block Micronucleus Assay [CBMN]. Higher
spontaneous micronuclei levels observed in patients suggest a higher
background level of genetic instability in the cancer patients. The next
step was to look into DRC within oral cancer cases and control
populations. This was done by the Host Cell Reactivation assay
(HCR), which measures the expression level of UV damaged reporter
genes. DRC% was correlated with SNPs in the DNA repair genes
XRCC1, XRCC3, ERCC2 and ERCC1. Suboptimal DRC was
observed in case of patients compared to control subjects which was
associated with a two to threefold increased risk of oral cancer. It was
seen that as repair capacity diminished, the probability of being a case
increased. In addition to SNPs as cancer susceptibility markers, we
also looked into their possible role as biomarkers of radiation treat-
ment (RT) response. Patients with polymorphic variants in their
genome responded better to RT as was evident from their complete
response and no evidence of disease after a follow up period of
3 years. To the best of our knowledge this is the first study, which
suggests a role for repair gene polymorphisms in influencing treat-
ment protocols.
302: Molecular genetic analyses of tumours
from colorectal cancer patients suggest existence
of alternate tumourigenesis pathway(s) in young
patients from India
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Colorectal cancer (CRC) is thought to be an age related disease, and
usually occurs in older patients ([60 years). Familial syndromes
resulting in an early occurrence of CRC account for a small propor-
tion of CRC patients in the west and mainly include Familial
Adenomatous Polyposis (FAP) and Hereditary Non Polyposis Colo-
rectal Cancer (HNPCC). Deregulated WNT signaling and
chromosomal instability have been reported in a majority (*70–
85%) of CRC patients resulting from mutational inactivation of the
adenomatous polyposis coli (APC) tumor suppressor gene. Another
form of genetic instability, the Microsatellite Instability (MSI), has
been shown to be responsible for approximately 15% of CRC cases. A
rise in the incidence of CRC among the young has recently been
reported in India. Unlike in the west these patients account for almost
1/3rd of the total CRC incidence (as per the local hospital registries)
and often succumb to aggressive metastatic tumors. We have
employed a multi-pronged strategy to study CRC occurring in young
patients including (a) identification of status of WNT signaling
through immunohistochemistry-based determination of intra cellular
localization of b-catenin, (b) screening for mutations in the APC
tumor suppressor gene, (c) screening for MSI, (d) identification of
copy number alteration through microarray based Comparative
Genomic Hybridization and (e) gene expression profiling using
microarray and real time RT-PCR. Our results reveal that a signifi-
cantly lower proportion (\40%) of tumors from young patients
exhibit an active WNT signaling pathway, as opposed to tumors from
older patients where the proportion is[75%, a statistically significant
difference (p \ 0.007, Fishers exact test). In addition, we identified
several novel mutations in the APC gene from WNT + tumors. We
could not detect any other significant difference between the two
classes of patients with respect to microsatellite instability, tumor
grade and stage, tumor location, gender, life style, etc. Our results
therefore suggest the existence of alternate tumorigenesis pathway(s)
in young sporadic CRC patients in India. We have initiated array-
based determination of copy number alteration and transcript profiling
to determine molecular signatures that govern rapid progression of
WNT-tumors. Initial studies have revealed a novel amplicon at
7q22.3 in a WNT-tumor. The present study is expected to yield
valuable insights into the molecular basis for young sporadic CRC.
303: Association of FCRL3 polymorphisms
with juvenile rheumatoid arthritis in Mexican
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Introduction: Juvenile rheumatoid arthritis (JRA) represents the most
common rheumatic disease of childhood. Recently, Kochi, et al.,
reported four single nucleotide polymorphisms (FCRL3_3-6) in the
FCRL3 gene strongly associated with susceptibility to several auto-
immune diseases, including arthritis, in Japanese population.
Furthermore, they observed that the allele C at the position-169C/T
(FCRL3_3) alters the binding affinity of nuclear factor-kappa B
affecting the FCRL3 expression, both in vivo and in vitro. FCRL3 gene
encodes a member of the Fc receptor like family involved mainly in
triggering activation of adaptative and innate effector cells, phagocy-
tosis, release of inflammation mediators, cellular cytotoxicity.
Objective: The aim of this study was to determine if polymorphisms in
the FCRL3 gene are associated with arthritis rheumatoid juvenile in a
sample of Mexican pediatric patients. Samples and methods. In a case-
control study we enrolled 157 patients, which meet the ACR classifi-
cation criteria for JRA and 350 unrelated healthy controls without
family history of autoimmune diseases. Both, cases and controls were
stratified by sex and ethnic origin. The SNPs were genotyped ussing
TaqMan assay. The association test, Hardy–Weinberg equilibrium
(HWE) and haplotypes were determined using EPIDAT, FINETTI and
Haploview softwares, respectively.
Results: Genotype distributions in cases and controls were in HWE.
The results showed strong evidence of association of three SNPs across
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FCRL3 gene with protection to JRA in this set of patients: FCRL3_3
(OR 0.54, 95% CI 0.34–0.82, p = 0.004), FCRL3_5 (OR 0.53, 95% CI
0.34–0.89, p = 0.003) y FCRL3_6 (OR 0.51, 95% CI 0.33–0.78,
p = 0.002). Furthermore, when the sample was stratified by gender,
distribution of the FCRL3 alleles reveled an association with protection
only to JRA males: FCRL3–3 (OR 0.53, 95% CI 0.34–0.82,
p = 0.004), FCRL3–5 (OR 0.48, 95% CI 0.30–0.74, p = 0.001),
FCRL3–6 (OR 0.46, 95% CI 0.30–0.72, p = 0.0006). The haplotype
harboring the 4 risk alleles CGCA, was also associated with protection
to JRA (OR 0.53, 95% CI 0.37–0.75, p = 0.0003). The three SNPs
showing association were on linkage disequilibrium (LD) (r2 0.88).
Conclusion: Interestingly, our results suggest that while in other
populations FCRL3 is associated with susceptibility to arthris in
adults, in Mexican population this gene confer protection to devel-
opment JRA and it seems that it is in a gender dependent manner.
304: Development of a web-enabled system for patient
data management and genetic analysis of diabetes
mellitus (DM)
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Diabetes mellitus (DM) is a complex multi factorial metabolic dis-
order, which involves genetic, epigenetic and environmental factors.
It is characterized by high blood sugar, beta cell dysfunction and
insulin resistance. Type 2 DM is the commonest form of diabetes,
which accounts for 90–95% of the diabetes population resulting from
insulin resistance combined with relative insulin deficiency. Type 1
DM is an autoimmune disease, which accounts for 5–10% of diabetic
cases. A diabetes patient needs to be monitored for a number of
clinical parameters such as blood sugar, cholesterol, insulin, blood
pressure; environmental parameters such as stress, diet, exercise etc.
Thus, the treatment procedure generates large amount of data.
Therefore, the availability of the complete patient record would be
useful to different specialists in rendering accurate treatment to the
patient. With a view to manage the voluminous data and to assist the
health care provider we have developed a web based data manage-
ment system. It is a searchable, client-server, relational database
application, developed on the WindowsTM platform using Oracle,
Active Server Pages (ASP), Visual Basic Script (VB Script) and Java
Script. This system, apart from assisting the medical practitioner(s), is
useful for analyzing the stored data as it provides the facility of
generating reports by querying the database using specific parameters.
An interactive web interface allows users to query the database and
generate reports. Thus, this system can be implemented by Pharma-
ceutical companies, R&D laboratories, geneticists, population
researchers, epidemiologists and nutritionists for research purposes.
As an application of this database for research, we have studied
inheritance of Diabetes mellitus in 3,921 individuals from 300 fam-
ilies in Maharashtra, India from the point of view of family history of
DM and disease occurrence as well as pattern of inheritance of dia-
betes with respect to maternal or paternal transmission, age of onset
etc. Detailed analysis of associated diseases has also been carried out.
We have used molecular genetic analysis to detect the polymorphisms
in the HNF1 gene in this population and have found SNPs and mis-
sense mutations that correlate with the incidence of DM. This analysis
thus provides a platform to systematically analyze the complex
interactions of environmental factors through epigenome which may
play a role in presentation of phenotype in this complex multifactorial
disease.
305: Interaction and integration of genes involved
in immune responses with special reference
to HLA-DRB1, HLA-B, Cytokine genes, Vitamin D
receptor and protein tyrosine phosphatase non-receptor
22 genes in type 1 diabetes
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Type 1 diabetes (T1D) is a complex, multifactorial autoimmune
disorder where at least 20 genomic intervals have been implicated.
However, since the disease is autoimmune in nature, we have studied
the interaction of alleles of genes involved in antigen presentation like
HLA-DRB1 and HLA-B with functional SNPs in pro and anti-
inflammatory cytokines, Vitamin-D-Receptor (VDR) and Protein
Tyrosine phosphatase non-receptor 22 (PTPN22). Although encoded
on different chromosomes, the products of these genes may interact in
integrated networks resulting in the manifestation of T1D. 235 T1D
patients were studied for HLA-DRB1 and HLA-B alleles using
Polymerase chain reaction (PCR) and hybridization with sequence
specific oligonucleotide probes using Luminex platform. The Single
nucleotide polymorphisms (SNP) for IFN-gamma (INFG A + 874T),
TNF-alpha (TNF G-308A), IL6 (G-174C), IL10 (A-1082G, T-819C,
C-592A), and TGF-beta1 (TGFB1 Tcdn10C, Gcdn25C) were studied
using PCR with sequence specific primers. Four single nucleotide
polymorphisms in the VDR gene (Fok1 site in Exon 2, Bsm1 and Apa
1 sites Intron 8 and Taq1 site in exon 9) were studied using PCR–
Restriction Fragment Length Polymorphism (PCR–RFLP) and a
functional SNP in the PTPN22 gene in the codon 620 at the nucle-
otide position 1858C [ T was also studied using PCR–RFLP.
An in-depth analysis of the data shows that while predisposing
HLA alleles, HLA-DRB1*0301, DRB1*0401 and DRB1*0405, may
have a role in antigen presentation, products of cytokine genes whose
amounts may be determined by SNPs in the cytokine genes, VDR
gene and PTPN22 also have integrated functional roles in manifes-
tation of the disease. VDR may have a role in the regulatory function
of 1,25–(OH)2D3 since vitamin D3 is the ligand for VDR and
Vitamin D3, in turn, has been shown to have an important immu-
nomodulatory role. PTPN22 which codes for a protein called
lymphoid tyrosine phosphatase (LYP) has been shown to be involved
in preventing spontaneous T-cell activation by dephosphorylation and
inactivating T-cell receptor associated kinases and their substrates.
The SNP in the codon 620 of PTPN22 gene results in an arginine to
tryptophan transition which may reduce the binding affinity of LYP to
cytoplasmic tyrosine kinase (Csk), which regulates the T-cell receptor
signaling. Data on interaction integration of these genes and the
implications there off to give the final verdict of Type 1 diabetes will
be presented.
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and pneumocystis pneumonia (PCP) susceptibility
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Pneumocystis pneumonia (PCP) is a fungal lung infection caused by
Pneumocystis jirovecii that remains a leading cause of morbidity and
mortality among HIV-infected individuals. PCP is extremely rare in
people with normal immune function but common among immuno-
compromised individuals. Although the innate and acquired immune
mechanisms against P. jirovecii are not fully understood, initiation of
an immune response is believed to be triggered by host recognition of
fungal beta-glucan cell wall components. Earlier studies have shown
that recognition of beta-glucan is partly mediated by the pattern-
recognition receptor CLEC7A (C-type lectin domain family 7,
member A; also known as Dectin-1). In the current study we aimed to
assess whether polymorphisms in the human CLEC7A gene affect
susceptibility to PCP among 263 HIV-infected UK Caucasian indi-
viduals. Nine haplotype-tagging SNPs spanning a 15 kb region across
CLEC7A on chromosome 12 were genotyped using Sequenom’s hME
chemistry. As CD4 + T cell deficiency clearly correlates with sus-
ceptibility to PCP, CD4 + cell count was included as a covariate in
the logistic regression model (SPSS 16.0 for Windows). One SNP in
the first intron (allelic p = 0.037; OR 2.74, 95% CI 1.06–7.06) and
the adjacent SNP in the promoter region of the gene (allelic
p = 0.0038; OR 4.01, 95% CI 1.57–10.28) showed apparent associ-
ation with PCP-susceptibility in the setting of HIV infection. Based
on LD structure, these nine genotyped SNPs can be divided in two
distinct haplotype blocks, with the two associating SNPs located in
the second block. Haplotype analysis of three SNPs in this second
block revealed one risk haplotype that can be tagged by the associ-
ating promoter SNP (p = 0.0038; OR 4.59, 95% CI 1.63–12.88) and
one protective haplotype (p = 0.0012; OR 0.42, 95% CI 0.25–0.71)
(haplotypes computed with a SNPHAP software). Since the sample
size is too small to make firm conclusions, a replication study of 319
Danish HIV-infected individuals is currently ongoing. Studies of host
genetic factors affecting susceptibility to PCP are scarce; the current
study suggests that host genetic factors may play an important role in
susceptibility to PCP among immunocompromised individuals.
307: Glutathione-S-Transferase P1 (GSTP1)
polymorphism and breast, colorectal and oral cavity
cancer risk among Filipinos
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Cancer is a multi-factorial disease that may occur as a result of the
interaction of genetics and the environment. Genetic factors by
themselves are thought to explain only about 5% of all cancers while
the remainder can be attributed to environmental factors that act in
conjunction with both genetic and acquired susceptibility. Numerous
population based studies have honed in on glutathione-S-transferase
genes as candidate cancer susceptibility genes because of their
involvement in the conjugation of glutathione to a multitude of car-
cinogens and their reactive intermediates thereby facilitating
detoxification and subsequent excretion. This particular study
employed only Filipino subjects and explored the association between
the c.313A [ G (p.I105 V) GSTP1 polymorphism in exon 5, and
incidence risk for 3 cancer sites: oral cavity (195 cases and 315
controls), colon and rectum (216 cases and 268 controls), and breast
(327 cases and 223 controls). Statistical analysis relating cancer risk
to various epidemiologic risk factors such as diet, chemical exposure
and medical history was also performed. Genotyping was done using
PCR–RFLP, and results were verified via direct sequencing. For
breast and colorectal cancer, matched univariate analysis revealed
that none of the GSTP1 genotypes yielded a statistically significant
result; for oral cavity cancer, the homozygous variant genotype (Val/
Val at amino acid pos. 105) was shown to significantly increase
individual risk for the disease (OR = 2.04, 95% CI: 1.01–4.12).
These results show that GSTP1 genotype has no effect on breast nor
colorectal cancer risk among Filipinos, while the homozygous
c.313A [ G genotype is a significant risk factor for oral cavity
cancer.
308: Enhancement of risk of oral leukoplakia
and cancer by combinations of polymorphisms
at NAT1, NAT2 and XRCC1
Bidyut Roy, Mousumi Majumder
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Introduction: The N-acetyl transferases (NATs) are important
enzymes that could acetylate N- or C-positions of tobacco carcino-
gens for detoxification or activation. Improper activities of these
enzymes might lead to the formation of DNA adducts that need
correction by DNA repair enzymes otherwise DNA adducts may
progress to mutation and finally tumor progression.
Methods: Here, genotypes at four SNPs on NAT1, five SNPs on NAT2
and three SNPs on XRCC1 were determined by PCR–RFLP and
Taqman methods in 389 controls, 224 leukoplakia and 310 cancer
patients. Genotypes at these loci were also expressed as haplotypes
and diplotypes by a maximum-likelihood method using the expecta-
tion maximization algorithm. Individuals can be assigned as NAT1
rapid, NAT1 normal, NAT2 slow, NAT2 intermediate and NAT2
rapid acetylators depending on the corresponding diplotypes present
in an individual. Genotype, haplotype and diplotype data at individual
locus and in combinations were analyzed to estimate the risk of oral
leukoplakia and cancer.
Results: Genotypes and diplotypes at NAT1 and NAT2 could not
modify the risk of diseases in this population. Genotypes at XRCC1
could not modify the risk of diseases but variant haplotypes could
increase the risk of leukoplakia marginally. The XRCC1 variant
haplotypes could also increase the risk of both cancer and leukoplakia
in mixed tobacco habitue´s only. Combining the NAT1 or NAT2 and
XRCC1 data in mixed tobacco habitue´s, it was observed that XRCC1
variant haplotypes enhanced the risk of leukoplakia and cancer with
increase in risk level (OR = 3.8, 95% CI = 1.7–8.5 and OR = 2.9,
95% CI = 1.4–6.2, respectively) in NAT1 rapid and (OR = 3.8, 95%
CI = 1.9–7.7 and OR = 2.8, 95% CI = 1.4–5.5, respectively) in
NAT2 slow acetylators compared to the risks attributed by XRCC1
variant haplotypes alone. Interestingly, combination of NAT1 rapid,
NAT2 slow and XRCC1 variant haplotypes increased the risk of
leukoplakia and cancer with enhancement of more risk (OR = 5.4,
95% CI = 1.8–16.5 and OR = 3.7, 95% CI = 1.3–10.6,
respectively).
Conclusion: None of the genotypes at these loci could modify the risk
of diseases independently but those at two or more loci, in combi-
nation, could increase the risk significantly in subsets of patients.
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309: Polymorphisms in the IL6 gene in Asian Indian
families with premature coronary artery disease:
The Indian Atherosclerosis research study
1P. R. Sannappa, 1A. Maitra, 1J. Shanker, 1D. Dash, 1S. John,
1V. S. Rao, 1J. K. Ramanna, 1,2V. V. Kakkar
1Thrombosis Research Institute India, Narayana Hrudayalaya
Hospital, 258/A Bommasandra Industrial Area, Anekal Taluk,
Bangalore 560099, India, 2Thrombosis Research Institute, Emmanuel
Kaye Building, Manresa Road, Chelsea, London SW3 6LR, UK
Inflammation plays a major role in coronary artery disease (CAD).
Interleukin-6 is an important inflammatory marker and a risk factor of
CAD. The present study was undertaken to investigate the association
of the interleukin-6 gene (IL6) polymorphisms with premature CAD
and their effect on the expression of acute-phase proteins in Asian
Indian families. One hundred and ninety affected sib pairs (ASPs)
were genotyped for three tag single nucleotide polymorphisms (SNPs)
of the IL6 gene by TaqMan allelic discrimination assays. We
observed suggestive linkage for one SNP (rs2066992) in a subset of
62 ASPs with an age at onset less than 45 years (LOD score = 1.114,
p = 0.011 in linkage analysis; pi = 0.008 in identity by descent).
Quantitative trait loci analysis indicated linkage of the genotypes with
plasma levels of high sensitivity C-reactive protein, hsCRP (LOD
score = 1.06, p = 0.014). Sequencing of the promoter region and
haplotype analysis was performed in 46 probands and 40 controls.
Five out of eight previously reported promoter SNPs were found to be
polymorphic in our cohort. Two novel sequence variants were found.
A promoter haplotype (GGAAG) was found to be associated with
premature CAD with an odds ratio of 3.676 (p = 0.0017, 95% CI:
1.68–8.045). The plasma levels of both hsCRP and fibrinogen
exhibited significant association with these promoter SNP genotypes
(p \ 0.001). In conclusion, IL6 gene polymorphisms appear to be
important genetic factors in premature CAD, and in the regulation of
key atherogenic markers in Asian Indian families.
310: Metabolic enzyme gene variants and oral cavity
cancer among Filipinos
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Oral cavity cancer is a leading cause of cancer among Filipinos, with
a 34% observed 5-year survival rate. Previous studies in other pop-
ulations have looked into the genetic risk for cancer which is
conferred by variants in xenobiotic-metabolizing enzyme genes. In
this study, DNA from 195 cases and 315 controls were genotyped via
PCR–RFLP and direct sequencing. After univariate analysis using
age-matched logistic regression, it was shown that homozygosity for
the c.313A [ G GSTP1 allele increased risk for oral cavity cancer
(OR 2.04; 95% CI: 1.01, 4.12), while homozygosity for the 30UTR
polymorphism of CYP1A1 has a protective effect (OR 0.52; 95% CI:
0.29, 0.92). The effect modification of various environmental factors,
such as smoking, alcohol and salty food intake and UV exposure were
also studied. These results may be helpful in elucidating the gene–
gene and gene–environment interactions which predispose to oral
cavity cancer among Filipinos.
311: Novel genetic variations in TNNT2 gene
are associated with hypertrophic and dilated
cardiomyopathies of Indian origin
1Deepa Selvi Rani, 2Patibha Nallari, 3P. S. Dhandapani,
4S. Tamilarasi, 5C. Narasimhan, 6Dharma Rakshak, 1Lalji Singh,
1Kumarasamy Thangaraj
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Cardiomyopathies are diseases of heart muscle that may result from a
diverse array of conditions that damage the heart and impair myocardial
function. Due to the genetic heterogeneity and the variable clinical
expressivity of these diseases, the relations between genotype and
phenotype remain complex. Since Indian populations are prone to high
degree of cardiac disorders, due to their unique population structures
and exposure to different life style, this study was aimed to screen for
mutations in cardiac trophonin T2 (TNNT2) gene in Indian patients
with hypertropic (HCM) and dilated cardiomyopathy (DCM). We have
analysed all the exons, including the exon-intron boundaries of the
above genes in a total of 384 patients, (including 200 HCM and 184
DCM patients) along with 110 ethnically matched controls. Mutation
analysis revealed a total of five exonic mutations, of which three of them
were novel and non-synonymous mutations changing the amino acids.
Of the three mutations, one (A27 V) was observed in a HCM patient and
the remaining two (R141Q, R144W) were observed in DCM patients.
One synonomous mutation found only in dilated cardiomyopathy.
Interestingly, one splice acceptor site mutation was observed in the
exon 12 of a dilated cardiomyopathy patient. Seven intronic mutations
were observed in introns 5, 6, 11, 12, 15 and 16. Further, 5 bp deletion/
deletion polymorphism in intron 3 and its association with predisposi-
tion to HCM was also studied. Our analysis revealed that the Indian
populations have significant number of novel mutations, which could be
responsible for the additional genetic causes. A details data with
functional significance would be presented during the conference.
312: Genetic studies on the APOA1-APOC3-APOA5
gene cluster in Asian Indians with premature Coronary
Artery Disease
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The APOA1-APOC3-APOA5 (Apo11q) gene cluster, located in the
11q23-24 chromosomal region, plays an important role in lipid
regulation. Given that Asian Indians have a tendency towards
exhibiting abnormal lipid levels and carry a high risk of coronary
artery disease (CAD), the present study aimed to elucidate the
relationship of four single nucleotide polymorphisms (SNPs) in the
Apo11q cluster (-75G [ A [rs1799837] and +83C [ T [rs5069]
SNPs in the APOA1 gene, the 3238C [ G [rs5128] SNP [Sac1] in
the APOC3 gene and the S19 W [rs3135506] variant in the APOA5
gene) to circulating levels of plasma lipids and CAD in 190
affected sibling pairs (ASPs) belonging to Asian Indian families
with strong history of premature CAD. Genotyping and lipid assays
were carried out using standard protocols. Plasma lipids, namely
Total cholesterol (TC), Triglycerides (TG), High density lipopro-
tein-cholesterol (HDL-c), showed strong heritability (h2 [ 48–70%;
p \ 0.0001). A subset of 77 ASPs showed significant linkage to
CAD trait by multi-point analysis (LOD score 7.42, p \ 0.001) and
to the Sac1 (LOD score 4.49) and the -75G [ A (LOD score 2.77)
SNPs by single-point analysis (p \ 0.001). There was significant
proportion of mean allele sharing (pi) (p \ 0.001), identity by
descent, for the Sac1 (pi 0.59), the -75G [ A (pi 0.56) and the
+83C [ T (pi 0.52) SNPs, respectively. Quantitative trait loci
analysis demonstrated suggestive evidence of linkage of the Sac1
SNP to TC, HDL-c and Apolipoprotein B (LOD score 1.42, 1.72,
1.19, respectively; p \ 0.01). The Sac1 and the -75G [ A SNPs
along with hypertension showed maximized correlations with TC,
TG and Apolipoprotein B levels. In conclusion, the Sac1 SNP in
the APOC3 gene is an important genetic variant for premature
CAD through its association with established risk factors such as
dyslipidemia among Asian Indians.
313: Role of OPRM1 gene in T2DM susceptibility
and its prevalence in North-West part of Rajasthan
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Prevalence of Type 2 Diabetes Mellitus (T2DM) varies from\2% in
rural Kashmir to [20% in urban areas of Hyderabad as reported by
different studies in India. International studies also report a wide
variation in T2DM prevalence. Genetic differences as well as dietary
factors have been implicated to explain these regional differences. In
India the prevalence of diabetes in the Riaca Community of North-
Western Rajasthan is extremely low, \0.5%. Agrawal et al. (2004)
conducted a cross-sectional survey of representative Raica and Non-
Raica community subjects and reported that both fasting as well as
post-glucose load, the glucose levels were significantly lower in Raica
community as compared to the Non-Raica individuals in the same
region. Agonists of mu-opioid receptor (OPRM1) affect glucose-
induced insulin release as seen in OPRM1 knockout mice which have
a more rapid induction of insulin resistance than their wild-type
counterpart. OPRM1 thus serves as an attractive positional candidate
gene for T2DM susceptibility. Gallagher et al. (2006) indeed detected
linkage of T2DM to 6q24-q27 using a genome-wide scan in African
Americans (AA) families and OPRM1 gene is located within the
6q24-q27 region. These associations suggested that the OPRM1 gene
may play a role in T2DM susceptibility in AA. Taking cue from these
reports the present study aims to delineate the frequency of C17T
(Ala6Val) and A118G (Asn40Asp) SNPs in exon I of OPRM1 gene in
subjects of Raica (n = 58) and Non-raica (n = 40) community and
study their association with the incidence of T2DM in diabetic sub-
jects (n = 39) from north-west Rajasthan. C17T (rs 1799972) and
A118G (rs 1799971) were genotyped using polymerase chain reac-
tion-restriction fragment length polymorphism (PCR–RFLP) method.
A significant association was observed between the C17T (Ala6Val)
allele and no association was seen with A118G (Asn40Asp) poly-
morphism and T2DM. The frequency of 17T allele was significantly
higher in Raica (0.48), in comparison to Non-Raica (0.30)
(p = 0.0159) and non-raica diabetic (0.36) subjects population
whereas no difference was observed in the frequency of 118G allele.
The raica community members did not have any cases of T2DM for
comparison. The population of northwestern Rajasthan in general
seems to have a higher prevalence of 17T allele as compared to other
regional populations from India. In the North Indians C17T reveals a
frequency of 0.11 whereas a frequency of 0.45 is observed in indi-
viduals of Rajasthan origin.
314: MTHFR gene polymorphisms among Aggarwals:
A community specific case control study for CAD
1Ekata Sinha, 2B. P. Gupta, 1K. N. Saraswathy
1Department of Anthropology, University of Delhi, India,
2Aggarwal Dharmarth Hospital, Shakti Nagar, India
Coronary Artery Disease (CAD) is the leading cause of death in world
which is belived to be caused by many genetic and environmental
factors. MTHFR gene is one of the 400 reported candidate gene for
CAD. MTHFR enzyme converts 5, 10 Methylenetetrahydro folate to
5-Methylenetetrahydro folate, the failure of which causes increased
levels of Homocystein in blood. The present study attempts to assess
the role of two polymorphisms 677T-C and 1298A-C in CAD. 100
CAD patients and 100 age, sex matched controls are screened for the
mutation among Aggarwals of Delhi. The mutated allele T (28%) and
C (22%) of C677T and A1298C polymorphism, respectively, are
found to be in higher frequency among cases. Significant difference
between cases and controls with an odds ratio i.e., 2.29 (95%
CI = 1.22–4.28) and 2.03 (95% CI = 1.047–3.94) for C677T and
A1298C, respectively, indicates that the two mutation are risk factors
for CAD, specifically among Aggarwal community.
315: Role of DNA Repair gene polymorphisms
in gallbladder cancer
1Kshitij Srivastava, 1Anvesha Srivastava, 1S. N. Pandey,
2G. Choudhuri, 1B. Mittal
1Department of Genetics, SGPGIMS, Raibareilly Road, Lucknow,
India, 2Department of Gastroenterology, SGPGIMS, Raibareilly
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Introduction: Gallbladder cancer (GBC) is the most common biliary
tract cancer with highest incidence rate in North India. Carcinogenesis
has been linked with increased DNA damage by endogenous or
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exogenous agents like reactive oxygen species (ROS), free radicals
and peroxides. Cells overcome these damages by specialized DNA
repair pathways one of which is base excision repair (BER) pathway.
Genetic polymorphisms in OGG1 and XRCC1, two important
enzymes participating in BER pathway may be involved in influ-
encing inter-individual variations in DNA repair capacity, which may
be associated with susceptibility to GBC.
Objective: This study was aimed to examine the role of OGG1
Ser326Cys (C [ G, rs1052133), XRCC1 Arg399Gln (G [ A, rs1799
782) and XRCC1 Arg194Trp (C [ T, rs25487) polymorphisms in
susceptibility to GBC.
Methodology: A case-control study (173 GBC patients and 204
controls) was used to test the association between the three poly-
morphisms and risk of GBC. Genotyping for all three polymorphisms
was done by PCR–RFLP method.
Results: All the studied polymorphisms were consistent with Hardy–
Weinberg equilibrium in controls. OGG1 Cys/Cys genotype frequency
was significantly higher in GBC patients [p = 0.025; Odds Ratio
(OR) = 2.93; 95% Confidence Interval (CI) = 1.14–7.51]. The
increased risk was more pronounced in GBC patients with gallstones
(p = 0.001; OR = 5.50; 95% CI = 1.99–15.16), females (p = 0.029;
OR = 5.92; 95% CI = 1.20–29.13) and late onset of disease
([50 years age) (p = 0.010; OR = 4.72; 95% CI = 1.43–15.53). In
XRCC1 Arg399Gln polymorphism, Gln/Gln and Arg/Gln genotypes
conferred low risk for the disease. (p = 0.039 and 0.003; OR = 0.68
and 0.37, respectively). However, XRCC1 Arg194Trp polymorphism
was not associated with GBC risk. Also, carriers of Arg-Gln haplotype
of XRCC1 were at significantly low risk for GBC (p = 0.002;
OR = 0.59, 95% CI = 0.42–0.82). The interaction of genotypes and
tobacco usage did not modulate the risk for GBC.
Conclusion: Results suggest that Cys/Cys genotype of OGG1 Ser326-
Cys polymorphism is associated with GBC susceptibility. However,
further studies are needed to strengthen its role in GBC pathogenesis.
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Dilated cardiomyopathy (DCM) is a disorder of the cardiac muscle.
Dilated cardiomyopathy inherits in an autosomal dominant mode. The
estimated prevalence is 1:500 in the general population and has
worldwide distribution among all ethnic groups. Patients with DCM
exhibit clinical manifestations that vary from an asymptomatic con-
dition to that of severe heart failure that leads to sudden cardiac death.
Here we report that an inherited human dilated cardiomyopathy with
refractory congestive heart failure is caused by a dominant mutation in
phospholamban (PLN), a transmembrane phosphoprotein that inhibits
the cardiac sarcoplasmic reticular Ca2+-adenosine triphosphatase
(SERCA2a) pump. It is also clear that the variations do not fully
explain the degree of variability in the phenotypic expression. The
patients were evaluated by clinical history, physical examination,
electrocardiogram and echocardiography. All PCR products were
analyzed for mutation by sequencing. It is expected that this finding
would provide direct evidence for the hypothesis that there is delete-
rious to the heart. Thus, we sought to determine the association
between the phenotype and genotype in an Indian family. These results
indicate that myocellular calcium dysregulation can initiate human
heart failure—a finding that may lead to therapeutic opportunities.
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The replication of Hepatitis B virus (HBV) proceeds via an obligatory
reverse transcription step in the viral capsid. cDNA is potentially
vulnerable to editing by cytidine deaminases of the APOBEC3 fam-
ily. G to A hypermutation of HBV and retroviruses appears as a result
of deamination activities of host APOBEC proteins and is thought to
play a role in innate antiviral immunity. Alpha and gamma interferons
have been reported to upregulate the transcription of APOBEC3G,
which is known to reduce the replication of HBV. Several recent
studies have brought increased attention to classes of genomic vari-
ation such as deletions, inversions, and copy-number polymorphisms.
It is thought that these variations contribute substantially to inter-
individual genotypic, and perhaps phenotypic, variation, but the
structure and population characteristics of these variants remain lar-
gely unexplored. A deletion in the APOBEC3 gene cluster was
recently identified that spans * 350 bp. Individuals possessing this
structural variant would lack at least one copy of the unique coding
portion of APOBEC3B. In this study, we report a deletion polymor-
phism in normal and HBV positive patients which results in
APOBEC3B deletion. In 96 normal individuals, the deletion fre-
quency was 1.39% revealing that there is low preference in favor of
deletion in this population as compared to other populations (Kidd et.
Al., unpublished). To understand the influence of this deletion on
HBV infection, we investigated the insertion/deletion polymorphism
of APOBEC3 gene in 75 patients with chronic hepatitis B (CHB) and
79 non-CHB patients by a genotyping PCR (Kidd et al., unpublished).
The frequency of homozygous deletion was 1.33 and 1.26%,
respectively, and that of heterozygous insertion/deletion was 24 and
22.78%, respectively, for CHB and non-CHB patients. Thus, the
deletion frequency within the APOBEC3 gene in HBV positive
patients is similar to that in normal individuals. It has been shown that
exposed ssDNA regions in the gene undergoing transcription are the
targets of APOBEC3 deaminases causing mutation in the pathogen
genome. Thus, the presence of APOBEC3B gene is more likely to be
in an environment where there is high viral threat, similar to our
observations. However, a high insertion frequency indicates the
presence of APOBEC3B in most of the patients, contrary to our
expectation. The answer may lie in the variable expression levels of
APOBEC3 in the liver cells, this, however, warrants further
investigations.
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Normal levels of blood glucose are maintained through integrated
mechanisms of glucose sensing, insulin production and glucose uti-
lization. Hence, pancreatic b-cells occupy the central role in
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maintaining glucose homeostasis and defects in its development and
function can result in imbalances in glucose metabolism and diabetes.
Hence, FOXA2 being an upstream activator of b-cell transcription
factor network regulating the development and function of adult
b-cells might be a key player in the manifestation of type 2 diabetes.
Therefore, here we examined the association of genetic variants of
FOXA2 with type 2 diabetes and related phenotypes in North India.
We performed case-control analysis of FOXA2 SNPs (rs1212275,
rs1055080, rs6048205) and (TCC)n repeat polymorphism in 1,656
North Indian participants of Indo-European ethnicity including 1,031
patients with type 2 diabetes and 625 control subjects. SNPs
rs1212275 and rs6048205 were found to be uncommon (MAF \ 5%)
with similar distribution among patients and controls. We found
strong association of (TCC)n common allele A5 and type 2 diabetes
with A5 homozygotes having odds ratio of 1.66 (95% CI 1.36–2.04,
p = 5.9 9 10-7). Obese individuals with A5A5 genotype had
enhanced risk of type 2 diabetes when segregated from normal-weight
subjects [OR = 1.92 (95% CI 1.47–2.51), p = 1.6 9 10-6]. A5 was
also nominally associated with higher fasting glucose (p = 0.02) and
lower fasting insulin (p = 0.0028) and C-peptide (p = 0.036) levels
among controls. At rs1055080 locus, GG was found to provide
reduced risk among normal-weight subjects [OR = 0.59 (95% CI
0.40–0.88), p = 0.011]. Combination of protective GG and non-risk
genotypes of (TCC)n showed reduced risk of type 2 diabetes both
among normal-weight [OR = 0.43 (95% CI 0.29–0.65),
p = 1.2 9 10-6] and obese individuals [0.47 (95% CI 0.34–0.64),
p = 4.3 9 10-5]. For the first time we demonstrate that FOXA2
variants may influence the risk of type 2 diabetes and affect the
metabolic traits in North India with (TCC)n locus and rs1055080
having opposing effects.
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In the present study 280 hypertensives and 200 normotensives were
studied to evaluate the risk of leptin (LEP) and leptin receptor (LEPR)
polymorphisms (a terta nucleotide polymorphism) for developing
essential hypertension. LEP and LEPR genotyping was done by PCR
amplification and separation of the short or class I (\160 bps) and
longer or class II ([160 bps) alleles for LEP and short(S, \158 bps)
and longer (L, [158 bps) alleles for LEPR genes using 9% acryl-
amide gels.
There was higher prevalence of males (54.6%) among hyperten-
sives with 66.3% of the cases having positive family history which
was twice that is found in controls. Age at onset of hypertension
varied from 35 to 60 years with modal frequency lying between 40
and 55 years. Biochemical analysis showed an increase in the mean
levels of triglycerides and decrease in HDL in hypertensives as
compared to controls. Distribution of genotypes of LEP gene differed
significantly (v2 -12.72, p = 0.001) between patients and controls
(22.9% of I/I, 25.4% of I/II and 51.8% of II/II in hypertensives and
15.0% of I/I; 40.0% of I/II and 45.0% of II/II in controls). This
suggests protection for heterozygotes against hypertension and high
risk was for both the homozygotes. Stratification of the data revealed
significant variation in the distribution of LEP genotypes in males (v2
-6.87, p = 0.03) cases with positive family history (v2 -11.5,
p = 0.003), low BMI (v2 -10.7, p = 0.005) and those with the habit
of smoking (v2 -6.25, p = 0.044) and alcohol consumption (v2 -
11.5, p = 0.004). Lipid profiles though were elevated in hyperten-
sives did not differ significantly from controls and also between
different genotypes within the patient and control groups. Distribution
of LEPR genotype did not vary significantly though there was ele-
vation of homozygosity for longer fragments (L/L) in patients as
compared to controls. When interaction between the genotypes of
LEP and LEPR were tested, risk for hypertension was found to be
higher in individuals with LEP I/I and LEPR L/L combination of
genotypes as compared to controls. Leptin gene which is strongly
associated with obesity has not shown any difference between obese
and non-obese hypertensive patient suggesting that the association of
LEP polymorphisms found in present hypertensives cases is inde-
pendent of obesity.
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Obstructive coronary artery disease (CAD) is characterized by the
deposition of atherosclerotic plaque on the coronary artery wall. Its
manifestations depend on interactions between environmental and
genetic risk factors. The Atherogenic profile of plasma lipoproteins is
characterized by elevated concentration of plasma triglycerides (TG)
and by a predominance of small dense LDL and low HDL cholesterol.
Small HDL particles and a lack of larger HDL particles also con-
tribute to the plasma atherogenic profile. Aim of the study was to
analyze the frequency of methylenetetrahydrofolate reductase
(MTHFR) C677T polymorphism in patients with CAD and its asso-
ciation with atherosclerotic index of plasma (AIP) levels. Risk factors
for CAD were also evaluated. A Prospective case control study has
performed. Two hundred and forty-nine angiographically proven
CAD patients and two hundred twenty three age sex matched healthy
individuals as control were studied. All individual filled a clinical
performa to analyze risk factors for CAD. MTHFR polymorphism
was investigated by restriction fragment length analysis and corre-
lated with the number of affected arteries and degree of arterial
obstruction determined by coronary angiography, and biochemical
investigations in all individuals. AIP were calculated by calculating
log TG/HDL. The T allele frequency was found insignificantly
associated with coronary artery disease (p = 0.078, OR 1.51),
However, in terms of risk factor associated with CAD the T allele
frequency has found significantly associated with hypertension
(p = 0.031, OR 2.12), Diabetes (p = 0.032, OR 2.04) and Smoking
(p = 0.019, OR 2.38) and insignificantly associated with positive
family history (p = 0.70). While Atherosclerotic index of plasma was
found to be significantly (p = 0.04) associated with C677T poly-
morphism. The present study indicates that CT + TT genotype in
patient group is insignificant associated with number of obstructed
vessels (p = 0.69).
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321: Molecular markers in idiopathic pulmonary
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Idiopathic Pulmonary Arterial Hypertension is a disease characterized
by sustained elevation of mPAP [25 mmHg at rest or [30 mmHg
during exercise, without an underlying cause. There is progressive
narrowing of the Pulmonary artery, that impedes the blood flow from
the right ventricle to the lungs, eventually leading to right ventricular
failure. IPAH is characterized by vasoconstriction of the small pul-
monary arteries, proliferation in all layers of the vessel wall,
thrombosis-in situ, and inflammation. The disease is rare with esti-
mated incidence being 1–2 cases per million in the general
population. The etiology of the disease still remains obscure. In the
present study genotyping of SLC6A4, SERPINE1, IL6 and IL1B
genes and SSCP analysis of the EDN1 (endothelin 1) and BMPR2
(Bone Morphogenetic Protein Receptor II) genes was carried out for
54 IPAH cases and 100 controls to identify possible genetic/molecular
risk markers. The BMPR2 gene is the identified candidate gene for
IPAH. We identified only 1 known mutation in exon 3 in 5 patients
but in Indian population it appears to have low frequency (9.25%),
clearly indicating genetic heterogeneity of the disease. Screening of
EDN1 gene revealed a known polymorphism-Ins A at +138 nucleo-
tide position from the transcription initiation site in 8 IPAH patients
and 3 controls. Genotypying of SLC6A4 promoter showed an
increased risk of IPAH with LL genotype when compared to SS
genotype (OR-3.106, CI-1.203, 8.095). OR of LS versus SS genotype
was also highly significant (OR-5.538, CI-2.185, 14.274). This data
further supports the implicated role of L allele in pathogenesis of
IPAH. Significant association of Hd2/Hd2 genotype of SERPINE1
was observed with IPAH as compared to Hd1/Hd1 and Hd1/Hd2
genotypes (OR-3.12, CI-1.08, 9.17). PAI-1 determines in part fibri-
nolysis activity and modulates the progression of thrombosis. Thus,
impaired fibrinolytic activity could play an integral role in the
development of thrombosis as seen in the disease. The odds test of
association was also found to be significant for CC genotype of (-511)
IL1B gene with IPAH cases when compared to TT genotype (OR-
2.59, CI-1.09, 6.17). IL-1 b is a proinflammatory cytokine that may
play significant role in proliferation of endothelial and smooth muscle
cells. The study has brought out the interactive role of these markers
and identification of susceptibility alleles influencing disease pro-
gression with poor prognosis.
322: Genome wide study of tuberculosis susceptibility
in West Africans reveal novel associations
Fredrik O. Vannberg, Emily Lyons, Sunny Wong, The Wellcome
Trust Case Control Consortium, The African Tuberculosis Genetics
Group, Adrian V. S. Hill
Wellcome Trust Centre for Human Genetics, Roosevelt Drive,
Oxford OX3 7BN, UK
Tuberculosis continues to cause substantial morbidity and mortality
throughput the world, especially in developing countries where
infrastructure and access to treatment is limited. Host genetics play
an important role in tuberculosis disease as demonstrated by twin
studies. Although many tuberculosis candidate gene studies have
been published many fail to replicate. We performed a genome
wide association study of tuberculosis susceptibility in a Gambian
population to determine genetic loci associated with tuberculosis
disease process. DNA was collected and genotyped for 1,498 pul-
monary tuberculosis cases and 1,496 population controls from The
Gambia. In total 429,403 SNPs were analysed to find 38 indepen-
dent loci associated with tuberculosis disease with P less than 10-4
and seven loci with P less than 10-5. The analysis revealed that
several of the associated genes are all related to NCAM1, sug-
gesting a role of this gene family in the development of pulmonary
tuberculosis. Replication studies are currently underway to attempt
to confirm these findings. Functional analysis of two of the loci
associated with tuberculosis has revealed differential TNF produc-
tion based upon genotype, suggesting a mechanism of protection
against tuberculosis.
323: SNPs in FTO and GNB3 are associated to obesity
in Mexican Mestizos
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2E. Garcia-G, 1G. Jimenez-Sanchez
1National Institute of Genomic Medicine, Mexico D.F., Mexico,
2National Institute of Medical Sciences, Mexico D.F., Mexico
Introduction: Morbid obesity is considered a global pandemia.
Approximately two thirds of the Mexican population are overweight
with a Body Mass Index (BMI) [ = 25 kg/m2, and close to 25% are
clinically obese. Previously published studies have suggested that
Hispanic Americans have a higher risk for the disease. As in other
Hispanic populations, most Mexicans are Mestizos, individuals
resulting from admixture of any of 65 ethnic groups, with Spaniards,
an in a lesser extent Africans. In order to increase our understanding
of the genetic basis of obesity in Mexicans, we aimed to analyze a
number of genetic polymorphisms already reported to be associated to
obesity in other populations.
Materials and Methods: We genotyped a set of 23 SNPs in a case-
control design in Mexicans. The selection of the SNP set was based
on their reported statistical significant association to obesity, repli-
cation and biological relevance. Cases and controls were selected
according to their BMI (C30 and B27 kg/m2, respectively). Ninety-
two controls and 138 cases were included (mean BMI ± SD in
cases = 26.7 ± 4.3 kg/m2 and in controls = 46.8 ± 10 kg/m2, p \
0.0001). About 50% of cases reported to have a first-degree obese
relative and/or to have obesity since childhood. We genotyped 23
SNPs in 13 genes: ADIPOQ (rs1501299, rs2241766, rs822396), LEPR
(rs1137100, rs1137101, rs8179183, rs13306526), LEP (rs17151919),
GNB3 (rs5443), MC3R (C_27859133), MC4R (rs13447335,
rs13447324, rs13447332), NR3C1 (rs6195, rs33391, 6192), AGRP
(rs5030980), ADRB3 (rs4994), ADRB2 (rs1042714), PPARG
(rs1801282), POMC (POMC87, rs1042571) and POMC158,
rs2071345) and FTO (rs8050136). To test for association we used
traditional Chi square analysis and Cochran–Armitage’s trend test.
Results: Our results showed evidence of association for rs5443 in
GNB3 (OR = 1.7 95% CI = [1.2–2.6], p = 0.007) and for rs8050136
in FTO (OR = 2.1 95% CI = [1.3–3.4], p = 0.002). In addition, we
observed that females were more obese than males (p = 0.0001), and
both, fat percentage and waist & hip ratio were significantly different
among the two groups (p \ 0.0001).
Conclusion: We found evidence that variants in GNB3 and FTO are
moderately associated to obesity in Mexican Mestizos. In order to
increase statistical power in our study we are increasing sample size
and further analyzing population stratification in our sample.
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324: Genetic studies in type 2 diabetes in south Indian
population
Radha Venkatesan, Mohan Viiswanathan
Madras Diabetes Research Foundation, 6B, Conran Smith Road,
Gopalapuram, Chennai, India
Type 2 diabetes results from the interaction of environmental factors
with genetic variants which confers susceptibility to the disease.
Recently, a systematic search for these variants using genome wide
approach was made possible the genotyping of thousands of poly-
morphisms and identification of new risk alleles for T2D. Some of
these have been replicated in multiple populations and provide novel
insights into the etiology of the disease. Evidence for increasing
prevalence of diabetes in India arises from the recent population
based studies conducted by us, the Chennai Urban Rural Epidemi-
ology Study(CURES), which revealed the present prevalence of
diabetes in urban India as 72% higher than that reported in 1989.
Indians with diabetes also have peculiar characteristics called Asian-
Indian phenotype. This includes low body mass index threshold for
diabetes, occurrence of the disease 2–3 decades earlier and herita-
bility factors being stronger in Indians compared to Europeans
pointing to the role of possible ethnic variation in genetic
susceptibility. Large population based genetic studies carried out by
us on some of the candidate genes or risk alleles, indicated interesting
results. The Pro12Ala polymorphism of the PPARG gene, which is
known to be protective against diabetes in Europeans, does not appear
to offer protection to Indians. We also observed that the Thr394Thr
(G [ A) polymorphism of PPARGC1A gene to be strongly associated
with T2D and with body fat in Indians which has not been reported in
other ethnic groups. The Gly1057Asp of IRS2 gene predisposes
Indians to diabetes particularly in the presence of obesity. Subjects
with TCF7L2 gene G [ T polymorphism at rs12255372 showed 1.5-
fold higher risk of having diabetes confirming similar association in
other populations. Our studies on the MODY 3 gene, HNF1A gene
yielded interesting results. The Ala98Val showed an association with
earlier age at onset of type 2 diabetes. We have also carried out
genetic studies on monogenic forms of diabetes. Our work on MODY
resulted in identification of novel mutations in HNF4A (MODY1) and
HNF1A (MODY3) genes. Co-segregation in large pedigree has also
shown novel MODY mutations in south Indian population. Our
studies on KCNJ11 gene in neonatal diabetes have also yielded
important results which will help in planning treatment modalities in
such patients. More large-scale and in-depth genetic studies are
underway which will help in determining subjects with high risk for
diabetes and in planning prevention strategies.
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